{
    "abstract": "The development of vaccines against polysaccharide-encapsulated pathogens (e.g. Haemophilus influenzae type b, pneumococci, meningococci) is challenging because polysaccharides do not elicit a strong and long-lasting immune response (i.e. T-cell independent). This can be overcome by conjugating the polysaccharide to a protein carrier (e.g. tetanus toxoid, cross-reacting material 197 [CRM]), which vastly improves the immune response and induces memory to the polysaccharide (T-cell dependent). Although it is well documented that protein carriers additionally induce an immune response against themselves, this potential \u201cadditional valency\u201d has so far not been recognized. The only exception is for the protein D carrier (derived from non-typeable Haemophilus influenzae [NTHi]) used in a pneumococcal conjugate vaccine, which may have a beneficial impact on NTHi acute otitis media. In this review, we describe the immunogenicity of various protein carriers and discuss their potential dual function: as providers of T-cell helper epitopes and as protective antigens. If this \u201cadditional valency\u201d could be proven to be protective, it may be possible to consider its potential effect on the number of required immunizations. We also describe the potential for positive or negative interference between conjugate vaccines using the same protein carriers, the resulting desire for novel carriers, and information on potential new carriers. The range of conjugate vaccines is ever expanding, with different carriers and methods of conjugation. We propose that new conjugate vaccine trials should assess immunogenicity to both the polysaccharide and carrier. Ultimately, this so-far \u201cneglected valency\u201d could be an exploitable characteristic of polysaccharide conjugate vaccines.",
    "author_highlights": [
        {
            "endOffset": 13540,
            "sentence": "Polysaccharides are conjugated to protein carriers to improve immune responses.",
            "startOffset": 13461
        },
        {
            "endOffset": 13608,
            "sentence": "Protein carriers also induce an immune response against themselves.",
            "startOffset": 13541
        },
        {
            "endOffset": 13692,
            "sentence": "This additional valency has only be recognized for NTHi protein D, used in PHiD-CV.",
            "startOffset": 13609
        },
        {
            "endOffset": 13778,
            "sentence": "Immunogenicity of various protein carriers and potential interferences are described.",
            "startOffset": 13693
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                }
            ],
            "doi": "10.1093/aje/kwh082",
            "firstpage": "634",
            "issn": "00029262",
            "lastpage": "644",
            "pmid": "15033641",
            "pub_year": 2004,
            "title": "Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases",
            "volume": "159"
        },
        "b0010": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Pace"
                }
            ],
            "doi": "10.1517/14712598.2012.725718",
            "firstpage": "11",
            "issn": "14712598",
            "lastpage": "33",
            "pmid": "22992106",
            "pub_year": 2013,
            "title": "Glycoconjugate vaccines",
            "volume": "13"
        },
        "b0015": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Gold"
                },
                {
                    "first": "M. L.",
                    "initial": "M.L.",
                    "last": "Lepow"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Goldschneider"
                },
                {
                    "first": "T. L.",
                    "initial": "T.L.",
                    "last": "Draper"
                },
                {
                    "first": "E. C.",
                    "initial": "E.C.",
                    "last": "Gotschlich"
                }
            ],
            "doi": "10.1172/JCI108235",
            "firstpage": "1536",
            "issn": "00219738",
            "lastpage": "1547",
            "pub_year": 1975,
            "title": "Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants",
            "volume": "56"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Oswald T.",
                    "initial": "O.T.",
                    "last": "Avery"
                },
                {
                    "first": "Walther F.",
                    "initial": "W.F.",
                    "last": "Goebel"
                }
            ],
            "doi": "10.1084/jem.50.4.533",
            "firstpage": "533",
            "issn": "00221007",
            "lastpage": "550",
            "pub_year": 1929,
            "title": "Chemo-immunological studies on conjugated carbohydrate-proteins: II. Imm-unological specificity of synthetic sugar-protein antigens",
            "volume": "50"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                }
            ],
            "doi": "10.1021/cb400423g",
            "firstpage": "1653",
            "issn": "15548929",
            "lastpage": "1663",
            "pmid": "23841819",
            "pub_year": 2013,
            "title": "Recent mechanistic insights on glycoconjugate vaccines and future perspectives",
            "volume": "8"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Fikri Y.",
                    "initial": "F.Y.",
                    "last": "Avci"
                }
            ],
            "firstpage": "2535",
            "issn": "18734294",
            "lastpage": "2540",
            "pmid": "24066893",
            "pub_year": 2013,
            "title": "Novel strategies for development of next-generation glycoconjugate vaccines.",
            "volume": "13"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Fikri Y.",
                    "initial": "F.Y.",
                    "last": "Avci"
                },
                {
                    "first": "Xiangming",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Moriya",
                    "initial": "M.",
                    "last": "Tsuji"
                },
                {
                    "first": "Dennis L.",
                    "initial": "D.L.",
                    "last": "Kasper"
                }
            ],
            "doi": "10.1038/nm.2535",
            "firstpage": "1602",
            "issn": "10788956",
            "lastpage": "1609",
            "pmid": "22101769",
            "pub_year": 2011,
            "title": "A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design",
            "volume": "17"
        },
        "b0040": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Chu"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Sutton"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Vann"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Vickers"
                },
                {
                    "first": "W. T.",
                    "initial": "W.T.",
                    "last": "London"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Curfman"
                },
                {
                    "first": "M. C.",
                    "initial": "M.C.",
                    "last": "Hardegree"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Shiloach"
                }
            ],
            "firstpage": "582",
            "issn": "00199567",
            "lastpage": "591",
            "pmid": "6332076",
            "pub_year": 1984,
            "title": "Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates",
            "volume": "45"
        },
        "b0045": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Parke"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Bell"
                },
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Schlesselman"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Sutton"
                },
                {
                    "first": "Z.",
                    "initial": "Z.",
                    "last": "Wang"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Schiffman"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Karpas"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Shiloach"
                }
            ],
            "firstpage": "519",
            "issn": "00199567",
            "lastpage": "528",
            "pmid": "3516876",
            "pub_year": 1986,
            "title": "Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates",
            "volume": "52"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Bermal"
                },
                {
                    "first": "Li Min",
                    "initial": "L.M.",
                    "last": "Huang"
                },
                {
                    "first": "Ashish P.",
                    "initial": "A.P.",
                    "last": "Dubey"
                },
                {
                    "first": "Hermant",
                    "initial": "H.",
                    "last": "Jain"
                },
                {
                    "first": "Ashish",
                    "initial": "A.",
                    "last": "Bavdekar"
                },
                {
                    "first": "Tzou Yien",
                    "initial": "T.Y.",
                    "last": "Lin"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.4161/hv.7.2.14068",
            "firstpage": "239",
            "issn": "15548600",
            "lastpage": "247",
            "pmid": "21343698",
            "pub_year": 2011,
            "title": "Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults",
            "volume": "7"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Charissa",
                    "initial": "C.",
                    "last": "Borja-Tabora"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Montalban"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1186/1471-2334-13-116",
            "issn": "14712334",
            "pmid": "23510357",
            "pub_year": 2013,
            "title": "Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: Results of an open, randomised, controlled study",
            "volume": "13"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Ghassan",
                    "initial": "G.",
                    "last": "Dbaibo"
                },
                {
                    "first": "Noel",
                    "initial": "N.",
                    "last": "Macalalad"
                },
                {
                    "first": "Mari Rose",
                    "initial": "M.R.",
                    "last": "Aplasca-De Los Reyes"
                },
                {
                    "first": "Efren",
                    "initial": "E.",
                    "last": "Dimaano"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                }
            ],
            "doi": "10.4161/hv.20211",
            "firstpage": "873",
            "issn": "2164554X",
            "lastpage": "880",
            "pmid": "22485050",
            "pub_year": 2012,
            "title": "The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: A randomized, controlled non-inferiority study",
            "volume": "8"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Ghassan",
                    "initial": "G.",
                    "last": "Dbaibo"
                },
                {
                    "first": "Nabil",
                    "initial": "N.",
                    "last": "El-Ayoubi"
                },
                {
                    "first": "Soha",
                    "initial": "S.",
                    "last": "Ghanem"
                },
                {
                    "first": "Farah",
                    "initial": "F.",
                    "last": "Hajar"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                },
                {
                    "first": "Narcisa",
                    "initial": "N.",
                    "last": "Mesaros"
                }
            ],
            "doi": "10.1007/s40266-013-0065-0",
            "firstpage": "309",
            "issn": "1170229X",
            "lastpage": "319",
            "pmid": "23494214",
            "pub_year": 2013,
            "title": "Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 years and older: Results of an open-label, randomized, controlled trial",
            "volume": "30"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Richarda M.",
                    "initial": "R.M.",
                    "last": "de Voer"
                },
                {
                    "first": "Liesbeth",
                    "initial": "L.",
                    "last": "Mollema"
                },
                {
                    "first": "Rutger M.",
                    "initial": "R.M.",
                    "last": "Schepp"
                },
                {
                    "first": "Sabine C.",
                    "initial": "S.C.",
                    "last": "de Greeff"
                },
                {
                    "first": "Pieter G.M.",
                    "initial": "P.G.M.",
                    "last": "van Gageldonk"
                },
                {
                    "first": "Hester E.",
                    "initial": "H.E.",
                    "last": "de Melker"
                },
                {
                    "first": "Elisabeth A.M.",
                    "initial": "E.A.M.",
                    "last": "Sanders"
                },
                {
                    "first": "Guy A.M.",
                    "initial": "G.A.M.",
                    "last": "Berbers"
                },
                {
                    "first": "Fiona R.M.",
                    "initial": "F.R.M.",
                    "last": "van der Klis"
                }
            ],
            "doi": "10.1371/journal.pone.0012144",
            "issn": "19326203",
            "pmid": "20730091",
            "pub_year": 2010,
            "title": "Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal C conjugate vaccine",
            "volume": "5"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Yuxiao",
                    "initial": "Y.",
                    "last": "Tang"
                },
                {
                    "first": "Ahmadu",
                    "initial": "A.",
                    "last": "Yakubu"
                },
                {
                    "first": "Prasad S.",
                    "initial": "P.S.",
                    "last": "Kulkarni"
                },
                {
                    "first": "F. Marc",
                    "initial": "F.M.",
                    "last": "La Force"
                }
            ],
            "doi": "10.1093/cid/civ512",
            "firstpage": "S570",
            "issn": "10584838",
            "lastpage": "S577",
            "pmid": "26553690",
            "pub_year": 2015,
            "title": "MenAfriVac as an antitetanus vaccine",
            "volume": "61"
        },
        "b0080": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Fattom"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Lue"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Szu"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Mestecky"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Schiffman"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Bryla"
                },
                {
                    "first": "W. F.",
                    "initial": "W.F.",
                    "last": "Vann"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Watson"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Kimzey"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schneerson"
                }
            ],
            "firstpage": "2309",
            "issn": "00199567",
            "lastpage": "2312",
            "pmid": "2365462",
            "pub_year": 1990,
            "title": "Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid",
            "volume": "58"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Cosette M.",
                    "initial": "C.M.",
                    "last": "Wheeler"
                },
                {
                    "first": "Bryan M.",
                    "initial": "B.M.",
                    "last": "Harvey"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Simon"
                },
                {
                    "first": "Stephen P.",
                    "initial": "S.P.",
                    "last": "Combs"
                },
                {
                    "first": "Mark M.",
                    "initial": "M.M.",
                    "last": "Blatter"
                },
                {
                    "first": "Gary S.",
                    "initial": "G.S.",
                    "last": "Marshall"
                },
                {
                    "first": "Gr\u00e9gory",
                    "initial": "G.",
                    "last": "Catteau"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Dobbelaere"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Descamps"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Dubin"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Schuind"
                }
            ],
            "doi": "10.1097/INF.0b013e31822d28df",
            "firstpage": "e225",
            "issn": "08913668",
            "lastpage": "e234",
            "pmid": "21817954",
            "pub_year": 2011,
            "title": "Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: Results from a randomized open trial",
            "volume": "30"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Br\u00f6ker"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "DeTora"
                },
                {
                    "first": "E. David",
                    "initial": "E.D.",
                    "last": "McIntosh"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                }
            ],
            "doi": "10.1016/j.biologicals.2011.05.004",
            "firstpage": "195",
            "issn": "10451056",
            "lastpage": "204",
            "pmid": "21715186",
            "pub_year": 2011,
            "title": "Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications",
            "volume": "39"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Br\u00f6ker"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1080/21645515.2016.1153206",
            "firstpage": "1808",
            "issn": "21645515",
            "lastpage": "1824",
            "pmid": "26934310",
            "pub_year": 2016,
            "title": "Factors contributing to the immunogenicity of meningococcal conjugate vaccines",
            "volume": "12"
        },
        "b0100": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Podda"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Vescia"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Donati"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Marsili"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Volpini"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Nencioni"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Mastroeni"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "G. M.",
                    "initial": "G.M.",
                    "last": "Fara"
                }
            ],
            "firstpage": "79",
            "issn": "11209135",
            "lastpage": "84",
            "pmid": "1725595",
            "pub_year": 1991,
            "title": "A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults",
            "volume": "3"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Scott A.",
                    "initial": "S.A.",
                    "last": "Halperin"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "McDonald"
                },
                {
                    "first": "Lindy",
                    "initial": "L.",
                    "last": "Samson"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Danzig"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Santos"
                },
                {
                    "first": "Allen",
                    "initial": "A.",
                    "last": "Izu"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Smith"
                },
                {
                    "first": "Noni",
                    "initial": "N.",
                    "last": "MacDonald"
                }
            ],
            "firstpage": "243",
            "issn": "0147958X",
            "lastpage": "251",
            "pmid": "12516995",
            "pub_year": 2002,
            "title": "Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: A randomized double-blind study",
            "volume": "25"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Gasparini"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Johnston"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Conversano"
                },
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Garscadden"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Alexanderian"
                },
                {
                    "first": "Noemi",
                    "initial": "N.",
                    "last": "Giglioli"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Percell"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Han"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Smolenov"
                }
            ],
            "doi": "10.4172/2157-7560.1000231",
            "issn": "21577560",
            "pub_year": 2014,
            "title": "Immunogenicity and safety of combined tetanus, reduced diphtheria, acellular pertussis vaccine when co-administered with quadrivalent meningococcal conjugate and human papillomavirus vaccines in healthy adolescents",
            "volume": "5"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Jodie",
                    "initial": "J.",
                    "last": "McVernon"
                },
                {
                    "first": "Jenny",
                    "initial": "J.",
                    "last": "MacLennan"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Clutterbuck"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Buttery"
                },
                {
                    "first": "E. Richard",
                    "initial": "E.R.",
                    "last": "Moxon"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00058-6",
            "firstpage": "2573",
            "issn": "0264410X",
            "lastpage": "2579",
            "pmid": "12744893",
            "pub_year": 2003,
            "title": "Effect of infant immunisation with meningococcus serogroup C-CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children",
            "volume": "21"
        },
        "b0120": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tashani"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Alfelali"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Barasheed"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Alqahtani"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Heron"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Wong"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Rashid"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Booy"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.10.020",
            "firstpage": "5929",
            "issn": "0264410X",
            "lastpage": "5937",
            "pmid": "27780630",
            "pub_year": 2016,
            "title": "Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial",
            "volume": "34"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Rose Marie",
                    "initial": "R.M.",
                    "last": "\u00d6lander"
                },
                {
                    "first": "Tomi",
                    "initial": "T.",
                    "last": "Wuorimaa"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Leroy"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Juhani",
                    "initial": "J.",
                    "last": "Eskola"
                }
            ],
            "doi": "10.1016/S0264-410X(01)00375-9",
            "firstpage": "336",
            "issn": "0264410X",
            "lastpage": "341",
            "pmid": "11672895",
            "pub_year": 2001,
            "title": "Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers",
            "volume": "20"
        },
        "b0130": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Pace"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Snape"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Westcar"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Oluwalana"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Yu"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Begg"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wysocki"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Czajka"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Maechler"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Boutriau"
                },
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1136/adc.2007.136036",
            "firstpage": "963",
            "issn": "00039888",
            "lastpage": "970",
            "pmid": "18463125",
            "pub_year": 2008,
            "title": "A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: A phase 3 open randomised controlled trial",
            "volume": "93"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Jo",
                    "initial": "J.",
                    "last": "Southern"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Rhonwen",
                    "initial": "R.",
                    "last": "Morris"
                },
                {
                    "first": "Pauline",
                    "initial": "P.",
                    "last": "Waight"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Hudson"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Balmer"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Findlow"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1128/CVI.00420-08",
            "firstpage": "194",
            "issn": "15566811",
            "lastpage": "199",
            "pmid": "19091990",
            "pub_year": 2009,
            "title": "Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the prevenar and pediacel vaccines in healthy infants in the United Kingdom",
            "volume": "16"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Br\u00f6ker"
                }
            ],
            "doi": "10.1080/21645515.2015.1086048",
            "firstpage": "664",
            "issn": "21645515",
            "lastpage": "667",
            "pmid": "26327602",
            "pub_year": 2016,
            "title": "Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates",
            "volume": "12"
        },
        "b0145": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Pecetta"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Lo Surdo"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Zambonelli"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Bottomley"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Biagini"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Buricchi"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Donnarumma"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Norais"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2014.11.026",
            "firstpage": "314",
            "issn": "0264410X",
            "lastpage": "320",
            "pmid": "25448110",
            "pub_year": 2015,
            "title": "Carrier priming with CRM197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation",
            "volume": "33"
        },
        "b0150": null,
        "b0155": {
            "authors": [
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "Forsgren"
                },
                {
                    "first": "Kristian",
                    "initial": "K.",
                    "last": "Riesbeck"
                },
                {
                    "first": "H\u00e5kan",
                    "initial": "H.",
                    "last": "Janson"
                }
            ],
            "doi": "10.1086/527396",
            "firstpage": "726",
            "issn": "10584838",
            "lastpage": "731",
            "pmid": "18230042",
            "pub_year": 2008,
            "title": "Protein D of Haemophilus influenzae: A protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines",
            "volume": "46"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Mustafa",
                    "initial": "M.",
                    "last": "Akkoyunlu"
                },
                {
                    "first": "H\u00e5kan",
                    "initial": "H.",
                    "last": "Janson"
                },
                {
                    "first": "Maorong",
                    "initial": "M.",
                    "last": "Ruan"
                },
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "Forsgren"
                }
            ],
            "doi": "10.1128/iai.64.11.4586-4592.1996",
            "firstpage": "4586",
            "issn": "00199567",
            "lastpage": "4592",
            "pmid": "8890211",
            "pub_year": 1996,
            "title": "Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae",
            "volume": "64"
        },
        "b0165": {
            "authors": [
                {
                    "first": "J. T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Bakaletz"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Cripps"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Denoel"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Forsgren"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Kyd"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Lobet"
                }
            ],
            "doi": "10.1016/S0264-410X(00)00288-7",
            "firstpage": "S108",
            "issn": "0264410X",
            "lastpage": "S115",
            "pmid": "11163473",
            "pub_year": 2000,
            "title": "Developing a nontypeable Haemophilus influenzae (NTHi) vaccine",
            "volume": "19"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Lauren O.",
                    "initial": "L.O.",
                    "last": "Bakaletz"
                },
                {
                    "first": "Bobbie Jo",
                    "initial": "B.J.",
                    "last": "Kennedy"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Novotny"
                },
                {
                    "first": "Guy",
                    "initial": "G.",
                    "last": "Duquesne"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "Yves",
                    "initial": "Y.",
                    "last": "Lobet"
                }
            ],
            "firstpage": "2746",
            "issn": "00199567",
            "lastpage": "2762",
            "pmid": "10338477",
            "pub_year": 1999,
            "title": "Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection",
            "volume": "67"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Matthew K.",
                    "initial": "M.K.",
                    "last": "Siggins"
                },
                {
                    "first": "Simren K.",
                    "initial": "S.K.",
                    "last": "Gill"
                },
                {
                    "first": "Paul R.",
                    "initial": "P.R.",
                    "last": "Langford"
                },
                {
                    "first": "Yanwen",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Shamez N.",
                    "initial": "S.N.",
                    "last": "Ladhani"
                },
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Tregoning"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.07.034",
            "firstpage": "4954",
            "issn": "0264410X",
            "lastpage": "4961",
            "pmid": "26212006",
            "pub_year": 2015,
            "title": "PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice",
            "volume": "33"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Peeters"
                },
                {
                    "first": "Viktor",
                    "initial": "V.",
                    "last": "Chrobok"
                },
                {
                    "first": "Pavla",
                    "initial": "P.",
                    "last": "Kriz"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Novakova"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Kaliskova"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Kohl"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Jean Paul",
                    "initial": "J.P.",
                    "last": "Prieels"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1016/S0140-6736(06)68304-9",
            "firstpage": "740",
            "issn": "01406736",
            "lastpage": "748",
            "pmid": "16517274",
            "pub_year": 2006,
            "title": "Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised double-blind efficacy study",
            "volume": "367"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Miguel W.",
                    "initial": "M.W.",
                    "last": "Tregnaghi"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e1ez-Llorens"
                },
                {
                    "first": "Pio",
                    "initial": "P.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Hector",
                    "initial": "H.",
                    "last": "Abate"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Smith"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "P\u00f3sleman"
                },
                {
                    "first": "Arlene",
                    "initial": "A.",
                    "last": "Calvo"
                },
                {
                    "first": "Digna",
                    "initial": "D.",
                    "last": "Wong"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Cortes-Barbosa"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Ceballos"
                },
                {
                    "first": "Marcelo",
                    "initial": "M.",
                    "last": "Tregnaghi"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Sierra"
                },
                {
                    "first": "Mirna",
                    "initial": "M.",
                    "last": "Rodriguez"
                },
                {
                    "first": "Marisol",
                    "initial": "M.",
                    "last": "Troiti\u00f1o"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Carabajal"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Falaschi"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Leandro"
                },
                {
                    "first": "Maria Mercedes",
                    "initial": "M.M.",
                    "last": "Castrej\u00f3n"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Lepetic"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "William P.",
                    "initial": "W.P.",
                    "last": "Hausdorff"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Javier Ruiz",
                    "initial": "J.R.",
                    "last": "Gui\u00f1az\u00fa"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Ortega-Barr\u00eda"
                },
                {
                    "first": "Juan P.",
                    "initial": "J.P.",
                    "last": "Yarz\u00e1bal"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1371/journal.pmed.1001657",
            "firstpage": "1",
            "issn": "15491277",
            "lastpage": "18",
            "pmid": "24892763",
            "pub_year": 2014,
            "title": "Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial",
            "volume": "11"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e1ez-Llorens"
                },
                {
                    "first": "Stella",
                    "initial": "S.",
                    "last": "Rowley"
                },
                {
                    "first": "Digna",
                    "initial": "D.",
                    "last": "Wong"
                },
                {
                    "first": "Mirna",
                    "initial": "M.",
                    "last": "Rodr\u00edguez"
                },
                {
                    "first": "Arlene",
                    "initial": "A.",
                    "last": "Calvo"
                },
                {
                    "first": "Marisol",
                    "initial": "M.",
                    "last": "Troiti\u00f1o"
                },
                {
                    "first": "Albino",
                    "initial": "A.",
                    "last": "Salas"
                },
                {
                    "first": "Vielka",
                    "initial": "V.",
                    "last": "Vega"
                },
                {
                    "first": "Maria Mercedes",
                    "initial": "M.M.",
                    "last": "Castrej\u00f3n"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Thierry G.",
                    "initial": "T.G.",
                    "last": "Pascal"
                },
                {
                    "first": "William P.",
                    "initial": "W.P.",
                    "last": "Hausdorff"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Ruiz-Gui\u00f1az\u00fa"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Ortega-Barr\u00eda"
                },
                {
                    "first": "Juan Pablo",
                    "initial": "J.P.",
                    "last": "Yarzabal"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1080/21645515.2017.1287640",
            "firstpage": "1213",
            "issn": "21645515",
            "lastpage": "1228",
            "pmid": "28368738",
            "pub_year": 2017,
            "title": "Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children\u2013A randomized controlled trial",
            "volume": "13"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Laura L.",
                    "initial": "L.L.",
                    "last": "Hammitt"
                },
                {
                    "first": "Donald O.",
                    "initial": "D.O.",
                    "last": "Akech"
                },
                {
                    "first": "Susan C.",
                    "initial": "S.C.",
                    "last": "Morpeth"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Karani"
                },
                {
                    "first": "Norbert",
                    "initial": "N.",
                    "last": "Kihuha"
                },
                {
                    "first": "Sammy",
                    "initial": "S.",
                    "last": "Nyongesa"
                },
                {
                    "first": "Tahreni",
                    "initial": "T.",
                    "last": "Bwanaali"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Mumbo"
                },
                {
                    "first": "Tatu",
                    "initial": "T.",
                    "last": "Kamau"
                },
                {
                    "first": "Shahnaaz K.",
                    "initial": "S.K.",
                    "last": "Sharif"
                },
                {
                    "first": "J. Anthony G.",
                    "initial": "J.A.G.",
                    "last": "Scott"
                }
            ],
            "doi": "10.1016/S2214-109X(14)70224-4",
            "firstpage": "e397",
            "issn": "2214109X",
            "lastpage": "e405",
            "pmid": "25103393",
            "pub_year": 2014,
            "title": "Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: Findings from cross-sectional carriage studies",
            "volume": "2"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Menno R.",
                    "initial": "M.R.",
                    "last": "Van Den Bergh"
                },
                {
                    "first": "Judith",
                    "initial": "J.",
                    "last": "Spijkerman"
                },
                {
                    "first": "Kristien M.",
                    "initial": "K.M.",
                    "last": "Swinnen"
                },
                {
                    "first": "Nancy A.",
                    "initial": "N.A.",
                    "last": "Fran\u00e7ois"
                },
                {
                    "first": "Thierry G.",
                    "initial": "T.G.",
                    "last": "Pascal"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                },
                {
                    "first": "Ed P.F.",
                    "initial": "E.P.F.",
                    "last": "Ijzerman"
                },
                {
                    "first": "Jacob P.",
                    "initial": "J.P.",
                    "last": "Bruin"
                },
                {
                    "first": "Arie",
                    "initial": "A.",
                    "last": "Van Der Ende"
                },
                {
                    "first": "Reinier H.",
                    "initial": "R.H.",
                    "last": "Veenhoven"
                },
                {
                    "first": "Elisabeth A.M.",
                    "initial": "E.A.M.",
                    "last": "Sanders"
                }
            ],
            "doi": "10.1093/cid/cis922",
            "firstpage": "e30",
            "issn": "10584838",
            "lastpage": "e39",
            "pmid": "23118268",
            "pub_year": 2013,
            "title": "Effects of the 10-valent pneumococcal nontypeable haemophilus influenzae protein d-conjugate vaccine on nasopharyngeal bacterial colonization in young children: A randomized controlled trial",
            "volume": "56"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Aino",
                    "initial": "A.",
                    "last": "Forsten"
                },
                {
                    "first": "Ilkka",
                    "initial": "I.",
                    "last": "Sepp\u00e4"
                },
                {
                    "first": "Tarja",
                    "initial": "T.",
                    "last": "Kaijalainen"
                },
                {
                    "first": "Taneli",
                    "initial": "T.",
                    "last": "Puumalainen"
                },
                {
                    "first": "Anu",
                    "initial": "A.",
                    "last": "Soininen"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Schoonbroodt"
                },
                {
                    "first": "Marjan",
                    "initial": "M.",
                    "last": "Hezareh"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Moreira"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1093/jpids/piw010",
            "firstpage": "237",
            "issn": "20487193",
            "lastpage": "248",
            "pmid": "27125273",
            "pub_year": 2016,
            "title": "Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland",
            "volume": "5"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Irena",
                    "initial": "I.",
                    "last": "Hanovcova"
                },
                {
                    "first": "Miroslav",
                    "initial": "M.",
                    "last": "Splino"
                },
                {
                    "first": "Pavla",
                    "initial": "P.",
                    "last": "Kriz"
                },
                {
                    "first": "Jitka",
                    "initial": "J.",
                    "last": "Motlova"
                },
                {
                    "first": "Vera",
                    "initial": "V.",
                    "last": "Lebedova"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Kaliskova"
                },
                {
                    "first": "Thierry",
                    "initial": "T.",
                    "last": "Pascal"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.12.086",
            "firstpage": "1959",
            "issn": "0264410X",
            "lastpage": "1967",
            "pmid": "21215830",
            "pub_year": 2011,
            "title": "Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage",
            "volume": "29"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Maria Cristina de C.",
                    "initial": "M.C.d.C.",
                    "last": "Brandileone"
                },
                {
                    "first": "Rosemeire C.",
                    "initial": "R.C.",
                    "last": "Zanella"
                },
                {
                    "first": "Samanta C.G.",
                    "initial": "S.C.G.",
                    "last": "Almeida"
                },
                {
                    "first": "Angela P.",
                    "initial": "A.P.",
                    "last": "Brandao"
                },
                {
                    "first": "Ana F.",
                    "initial": "A.F.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Telma Regina M.P.",
                    "initial": "T.R.M.P.",
                    "last": "Carvalhanas"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "Sato"
                },
                {
                    "first": "Ana L\u00facia",
                    "initial": "A.L.",
                    "last": "Andrade"
                },
                {
                    "first": "Jennifer R.",
                    "initial": "J.R.",
                    "last": "Verani"
                },
                {
                    "first": "Maria Luiza L.S.",
                    "initial": "M.L.L.S.",
                    "last": "Guerra"
                },
                {
                    "first": "Lincoln S.",
                    "initial": "L.S.",
                    "last": "do Prado"
                },
                {
                    "first": "S\u00e9rgio",
                    "initial": "S.",
                    "last": "Bokermann"
                },
                {
                    "first": "Ana Paula S.",
                    "initial": "A.P.S.",
                    "last": "Lemos"
                },
                {
                    "first": "Maria Cec\u00edlia O.",
                    "initial": "M.C.O.",
                    "last": "Gorla"
                },
                {
                    "first": "Bernadete",
                    "initial": "B.",
                    "last": "Liphaus"
                },
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Policena"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "da Gl\u00f3ria Carvalho"
                },
                {
                    "first": "Ana Paula S.",
                    "initial": "A.P.S.",
                    "last": "Sato"
                },
                {
                    "first": "Maria L\u00edgia",
                    "initial": "M.L.",
                    "last": "Nerger"
                },
                {
                    "first": "Monica T.",
                    "initial": "M.T.",
                    "last": "Conde"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2016.09.027",
            "firstpage": "5604",
            "issn": "0264410X",
            "lastpage": "5611",
            "pmid": "27692770",
            "pub_year": 2016,
            "title": "Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in S\u00e3o Paulo, Brazil",
            "volume": "34"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Amanda Jane",
                    "initial": "A.J.",
                    "last": "Leach"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Wigger"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Hare"
                },
                {
                    "first": "Vanya",
                    "initial": "V.",
                    "last": "Hampton"
                },
                {
                    "first": "Jemima",
                    "initial": "J.",
                    "last": "Beissbarth"
                },
                {
                    "first": "Ross",
                    "initial": "R.",
                    "last": "Andrews"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Chatfield"
                },
                {
                    "first": "Heidi",
                    "initial": "H.",
                    "last": "Smith-Vaughan"
                },
                {
                    "first": "Peter Stanley",
                    "initial": "P.S.",
                    "last": "Morris"
                }
            ],
            "doi": "10.1186/s12887-015-0483-8",
            "issn": "14712431",
            "pmid": "26482232",
            "pub_year": 2015,
            "title": "Reduced middle ear infection with nontypeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine",
            "volume": "15"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Amanda J.",
                    "initial": "A.J.",
                    "last": "Leach"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Wigger"
                },
                {
                    "first": "Jemima",
                    "initial": "J.",
                    "last": "Beissbarth"
                },
                {
                    "first": "Donna",
                    "initial": "D.",
                    "last": "Woltring"
                },
                {
                    "first": "Ross",
                    "initial": "R.",
                    "last": "Andrews"
                },
                {
                    "first": "Mark D.",
                    "initial": "M.D.",
                    "last": "Chatfield"
                },
                {
                    "first": "Heidi",
                    "initial": "H.",
                    "last": "Smith-Vaughan"
                },
                {
                    "first": "Peter S.",
                    "initial": "P.S.",
                    "last": "Morris"
                }
            ],
            "doi": "10.1016/j.ijporl.2016.05.011",
            "firstpage": "224",
            "issn": "01655876",
            "lastpage": "232",
            "pmid": "27260611",
            "pub_year": 2016,
            "title": "General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines",
            "volume": "86"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Amanda J.",
                    "initial": "A.J.",
                    "last": "Leach"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Wigger"
                },
                {
                    "first": "Ross",
                    "initial": "R.",
                    "last": "Andrews"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Chatfield"
                },
                {
                    "first": "Heidi",
                    "initial": "H.",
                    "last": "Smith-Vaughan"
                },
                {
                    "first": "Peter S.",
                    "initial": "P.S.",
                    "last": "Morris"
                }
            ],
            "doi": "10.1186/1471-2431-14-200",
            "issn": "14712431",
            "pmid": "25109288",
            "pub_year": 2014,
            "title": "Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules",
            "volume": "14"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Holst"
                },
                {
                    "first": "Diana",
                    "initial": "D.",
                    "last": "Martin"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Arnold"
                },
                {
                    "first": "Concepcion Campa",
                    "initial": "C.C.",
                    "last": "Huergo"
                },
                {
                    "first": "Philipp",
                    "initial": "P.",
                    "last": "Oster"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "O'Hallahan"
                },
                {
                    "first": "Einar",
                    "initial": "E.",
                    "last": "Rosenqvist"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.04.071",
            "firstpage": "B3",
            "issn": "0264410X",
            "lastpage": "B12",
            "pmid": "19481313",
            "pub_year": 2009,
            "title": "Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis",
            "volume": "27"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Germie P.J.M.",
                    "initial": "G.P.J.M.",
                    "last": "van den Dobbelsteen"
                },
                {
                    "first": "Harry H.",
                    "initial": "H.H.",
                    "last": "van Dijken"
                },
                {
                    "first": "Subramonia",
                    "initial": "S.",
                    "last": "Pillai"
                },
                {
                    "first": "Loek",
                    "initial": "L.",
                    "last": "van Alphen"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.09.025",
            "firstpage": "2491",
            "issn": "0264410X",
            "lastpage": "2496",
            "pmid": "17023098",
            "pub_year": 2007,
            "title": "Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs",
            "volume": "25"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Terry",
                    "initial": "T.",
                    "last": "Nolan"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Richmond"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Marshall"
                },
                {
                    "first": "Jodie",
                    "initial": "J.",
                    "last": "McVernon"
                },
                {
                    "first": "Karyn",
                    "initial": "K.",
                    "last": "Alexander"
                },
                {
                    "first": "Narcisa",
                    "initial": "N.",
                    "last": "Mesaros"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Aris"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                }
            ],
            "doi": "10.1097/INF.0b013e3181fcb2bf",
            "firstpage": "190",
            "issn": "08913668",
            "lastpage": "196",
            "pub_year": 2011,
            "title": "Immunogenicity and safety of an investigational combined Haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine",
            "volume": "30"
        },
        "b0250": {
            "authors": [
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Granoff"
                },
                {
                    "first": "E. L.",
                    "initial": "E.L.",
                    "last": "Anderson"
                },
                {
                    "first": "M. T.",
                    "initial": "M.T.",
                    "last": "Osterholm"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Holmes"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "McHugh"
                },
                {
                    "first": "R. B.",
                    "initial": "R.B.",
                    "last": "Belshe"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Medley"
                },
                {
                    "first": "T. V.",
                    "initial": "T.V.",
                    "last": "Murphy"
                }
            ],
            "doi": "10.1016/S0022-3476(05)81186-2",
            "firstpage": "187",
            "issn": "00223476",
            "lastpage": "194",
            "pmid": "1640282",
            "pub_year": 1992,
            "title": "Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants",
            "volume": "121"
        },
        "b0255": null,
        "b0260": {
            "authors": [
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Fred",
                    "initial": "F.",
                    "last": "Zepp"
                },
                {
                    "first": "Hans",
                    "initial": "H.",
                    "last": "Hallander"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                }
            ],
            "doi": "10.1586/erv.11.142",
            "firstpage": "1621",
            "issn": "14760584",
            "lastpage": "1631",
            "pmid": "22043960",
            "pub_year": 2011,
            "title": "Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules",
            "volume": "10"
        },
        "b0265": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Findlow"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1080/21645515.2015.1091908",
            "firstpage": "226",
            "issn": "21645515",
            "lastpage": "230",
            "pmid": "26619353",
            "pub_year": 2016,
            "title": "Interactions of conjugate vaccines and co-administered vaccines",
            "volume": "12"
        },
        "b0270": {
            "authors": [
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.06.026",
            "firstpage": "5513",
            "issn": "0264410X",
            "lastpage": "5523",
            "pmid": "20600514",
            "pub_year": 2010,
            "title": "Glycoconjugate vaccines and immune interference: A review",
            "volume": "28"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "Leszek",
                    "initial": "L.",
                    "last": "Szenborn"
                },
                {
                    "first": "Masnuel",
                    "initial": "M.",
                    "last": "Moro"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Petit"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Bermal"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Bernard"
                },
                {
                    "first": "Ilse",
                    "initial": "I.",
                    "last": "Dieussaert"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1097/INF.0b013e318199f61b",
            "firstpage": "S97",
            "issn": "08913668",
            "lastpage": "S108",
            "pmid": "19325452",
            "pub_year": 2009,
            "title": "Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV)",
            "volume": "28"
        },
        "b0280": {
            "authors": [
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Juhani",
                    "initial": "J.",
                    "last": "Eskola"
                },
                {
                    "first": "Claude",
                    "initial": "C.",
                    "last": "Leclerc"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Leroy"
                }
            ],
            "doi": "10.1128/iai.66.5.2093-2098.1998",
            "firstpage": "2093",
            "issn": "00199567",
            "lastpage": "2098",
            "pmid": "9573094",
            "pub_year": 1998,
            "title": "Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants",
            "volume": "66"
        },
        "b0285": {
            "authors": [
                {
                    "first": "Merryn",
                    "initial": "M.",
                    "last": "Voysey"
                },
                {
                    "first": "Manish",
                    "initial": "M.",
                    "last": "Sadarangani"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Clutterbuck"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Bolgiano"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.06.038",
            "firstpage": "3986",
            "issn": "0264410X",
            "lastpage": "3992",
            "pmid": "27349840",
            "pub_year": 2016,
            "title": "The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials",
            "volume": "34"
        },
        "b0290": {
            "authors": [
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Ra\u00efssa Nad\u00e8ge",
                    "initial": "R.N.",
                    "last": "Cabor\u00e9"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Niel",
                    "initial": "N.",
                    "last": "Hens"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.100",
            "firstpage": "142",
            "issn": "0264410X",
            "lastpage": "150",
            "pmid": "26592142",
            "pub_year": 2016,
            "title": "Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study",
            "volume": "34"
        },
        "b0295": {
            "authors": [
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Ra\u00efssa Nad\u00e8ge",
                    "initial": "R.N.",
                    "last": "Cabor\u00e9"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Vermeiren"
                },
                {
                    "first": "Niel",
                    "initial": "N.",
                    "last": "Hens"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.04.066",
            "firstpage": "3613",
            "issn": "0264410X",
            "lastpage": "3619",
            "pmid": "27142328",
            "pub_year": 2016,
            "title": "Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age",
            "volume": "34"
        },
        "b0300": {
            "authors": [
                {
                    "first": "Tzong Yueh",
                    "initial": "T.Y.",
                    "last": "Chen"
                },
                {
                    "first": "Chia Po",
                    "initial": "C.P.",
                    "last": "Lin"
                },
                {
                    "first": "Chien Chang",
                    "initial": "C.C.",
                    "last": "Loa"
                },
                {
                    "first": "Tso Ling",
                    "initial": "T.L.",
                    "last": "Chen"
                },
                {
                    "first": "Huey Fang",
                    "initial": "H.F.",
                    "last": "Shang"
                },
                {
                    "first": "Jaulang",
                    "initial": "J.",
                    "last": "Hwang"
                },
                {
                    "first": "Cho Fat",
                    "initial": "C.F.",
                    "last": "Hui"
                }
            ],
            "doi": "10.1007/BF02253525",
            "firstpage": "357",
            "issn": "10217770",
            "lastpage": "363",
            "pub_year": 1999,
            "title": "A nontoxic Pseudomonas exotoxin A induces active immunity and passive protective antibody against Pseudomonas exotoxin A intoxication",
            "volume": "6"
        },
        "b0305": {
            "authors": [
                {
                    "first": "O. R.",
                    "initial": "O.R.",
                    "last": "Pavlovskis"
                },
                {
                    "first": "D. C.",
                    "initial": "D.C.",
                    "last": "Edman"
                },
                {
                    "first": "S. H.",
                    "initial": "S.H.",
                    "last": "Leppla"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Wretlind"
                },
                {
                    "first": "L. R.",
                    "initial": "L.R.",
                    "last": "Lewis"
                },
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Martin"
                }
            ],
            "firstpage": "681",
            "issn": "00199567",
            "lastpage": "689",
            "pmid": "6788700",
            "pub_year": 1981,
            "title": "Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids",
            "volume": "32"
        },
        "b0310": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Hertle"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Mrsny"
                },
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Fitzgerald"
                }
            ],
            "doi": "10.1128/IAI.69.11.6962-6969.2001",
            "firstpage": "6962",
            "issn": "00199567",
            "lastpage": "6969",
            "pmid": "11598071",
            "pub_year": 2001,
            "title": "Dual-function vaccine for Pseudomonas aeruginosa: Characterization of chimeric exotoxin A-pilin protein",
            "volume": "69"
        },
        "b0315": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cryz"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Cross"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Wegmann"
                },
                {
                    "first": "J. U.",
                    "initial": "J.U.",
                    "last": "Que"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Fiirer"
                }
            ],
            "doi": "10.1093/infdis/163.5.1040",
            "firstpage": "1040",
            "issn": "00221899",
            "lastpage": "1045",
            "pmid": "1708398",
            "pub_year": 1991,
            "title": "Safety and immunogenicity of escherichia coli 018 o-specific polysaccharide (O-ps)-toxin a and o-ps-cholera toxin conjugate vaccines in humans",
            "volume": "163"
        },
        "b0320": {
            "authors": [
                {
                    "first": "Amina",
                    "initial": "A.",
                    "last": "Ahmed"
                },
                {
                    "first": "Jianpin",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Yossi",
                    "initial": "Y.",
                    "last": "Shiloach"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Bobbins"
                },
                {
                    "first": "Shousun C.",
                    "initial": "S.C.",
                    "last": "Szu"
                }
            ],
            "doi": "10.1086/499821",
            "firstpage": "515",
            "issn": "00221899",
            "lastpage": "521",
            "pmid": "16425130",
            "pub_year": 2006,
            "title": "Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children",
            "volume": "193"
        },
        "b0325": {
            "authors": [
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Cross"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Artenstein"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Que"
                },
                {
                    "first": "Terry",
                    "initial": "T.",
                    "last": "Fredeking"
                },
                {
                    "first": "Emil",
                    "initial": "E.",
                    "last": "Furer"
                },
                {
                    "first": "Jerald C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "J. Cryz",
                    "initial": "J.C.",
                    "last": "Stanley"
                }
            ],
            "doi": "10.1093/infdis/170.4.834",
            "firstpage": "834",
            "issn": "00221899",
            "lastpage": "840",
            "pmid": "7523536",
            "pub_year": 1994,
            "title": "Safety and immunogenicity of a polyvalent escherichia coli vaccine in human volunteers",
            "volume": "170"
        },
        "b0330": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cryz"
                },
                {
                    "first": "J. O.",
                    "initial": "J.O.",
                    "last": "Que"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Cross"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "F\u00fcrer"
                }
            ],
            "doi": "10.1016/0264-410X(94)00009-C",
            "firstpage": "449",
            "issn": "0264410X",
            "lastpage": "453",
            "pmid": "7639013",
            "pub_year": 1995,
            "title": "Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine",
            "volume": "13"
        },
        "b0335": {
            "authors": [
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Szu"
                },
                {
                    "first": "D. N.",
                    "initial": "D.N.",
                    "last": "Taylor"
                },
                {
                    "first": "A. C.",
                    "initial": "A.C.",
                    "last": "Trofa"
                },
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "Clements"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Shiloach"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                }
            ],
            "firstpage": "4440",
            "issn": "00199567",
            "lastpage": "4444",
            "pmid": "7927707",
            "pub_year": 1994,
            "title": "Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines",
            "volume": "62"
        },
        "b0340": {
            "authors": [
                {
                    "first": "Mai Ngoc",
                    "initial": "M.N.",
                    "last": "Lanh"
                },
                {
                    "first": "Phan",
                    "initial": "P.",
                    "last": "Van Bay"
                },
                {
                    "first": "Vo Anh",
                    "initial": "V.A.",
                    "last": "Ho"
                },
                {
                    "first": "Tran Cong",
                    "initial": "T.C.",
                    "last": "Thanh"
                },
                {
                    "first": "Feng Ying C.",
                    "initial": "F.Y.C.",
                    "last": "Lin"
                },
                {
                    "first": "Dolores A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "Chiayung",
                    "initial": "C.",
                    "last": "Chu"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Schiloach"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "Shousun C.",
                    "initial": "S.C.",
                    "last": "Szu"
                }
            ],
            "doi": "10.1056/NEJM200310023491423",
            "firstpage": "1390",
            "issn": "00284793",
            "lastpage": "1391",
            "pmid": "14523155",
            "pub_year": 2003,
            "title": "Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children [7]",
            "volume": "349"
        },
        "b0345": {
            "authors": [
                {
                    "first": "Ali I.",
                    "initial": "A.I.",
                    "last": "Fattom"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Horwith"
                },
                {
                    "first": "Steve",
                    "initial": "S.",
                    "last": "Fuller"
                },
                {
                    "first": "Myra",
                    "initial": "M.",
                    "last": "Propst"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Naso"
                }
            ],
            "doi": "10.1016/j.vaccine.2003.11.034",
            "firstpage": "880",
            "issn": "0264410X",
            "lastpage": "887",
            "pmid": "15040941",
            "pub_year": 2004,
            "title": "Development of StaphVAX\u2122, a polysaccharide conjugate vaccine against S. aureus infection: From the lab bench to phase III clinical trials",
            "volume": "22"
        },
        "b0350": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cryz"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Furer"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Germanier"
                }
            ],
            "firstpage": "161",
            "issn": "00199567",
            "lastpage": "165",
            "pmid": "3082756",
            "pub_year": 1986,
            "title": "Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine",
            "volume": "52"
        },
        "b0355": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cryz"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Furer"
                }
            ],
            "firstpage": "1829",
            "issn": "00199567",
            "lastpage": "1830",
            "pmid": "2454893",
            "pub_year": 1988,
            "title": "Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: Effects of a booster dose on antibody levels in humans",
            "volume": "56"
        },
        "b0360": {
            "authors": [
                {
                    "first": "U. B.",
                    "initial": "U.B.",
                    "last": "Schaad"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wedgwood"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ruedeberg"
                },
                {
                    "first": "A. B.",
                    "initial": "A.B.",
                    "last": "Lang"
                },
                {
                    "first": "J. U.",
                    "initial": "J.U.",
                    "last": "Que"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Furer"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cryz"
                }
            ],
            "doi": "10.1016/0140-6736(91)92103-9",
            "firstpage": "1236",
            "issn": "01406736",
            "lastpage": "1237",
            "pmid": "1682645",
            "pub_year": 1991,
            "title": "Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis",
            "volume": "338"
        },
        "b0365": {
            "authors": [
                {
                    "first": "Christoph F.R.",
                    "initial": "C.F.R.",
                    "last": "Hatz"
                },
                {
                    "first": "Bettina",
                    "initial": "B.",
                    "last": "Bally"
                },
                {
                    "first": "Susanne",
                    "initial": "S.",
                    "last": "Rohrer"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Steffen"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Kramme"
                },
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wacker"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Alaimo"
                },
                {
                    "first": "Veronica Gambillara",
                    "initial": "V.G.",
                    "last": "Fonck"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.06.102",
            "firstpage": "4594",
            "issn": "0264410X",
            "lastpage": "4601",
            "pmid": "26162850",
            "pub_year": 2015,
            "title": "Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study",
            "volume": "33"
        },
        "b0370": {
            "authors": [
                {
                    "first": "Neil",
                    "initial": "N.",
                    "last": "Ravenscroft"
                },
                {
                    "first": "Micha A.",
                    "initial": "M.A.",
                    "last": "Haeuptle"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Kowarik"
                },
                {
                    "first": "Fabiana S.",
                    "initial": "F.S.",
                    "last": "Fernandez"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Carranza"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Brunner"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Steffen"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wetter"
                },
                {
                    "first": "Sacha",
                    "initial": "S.",
                    "last": "Keller"
                },
                {
                    "first": "Corina",
                    "initial": "C.",
                    "last": "Ruch"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wacker"
                }
            ],
            "doi": "10.1093/glycob/cwv077",
            "firstpage": "51",
            "issn": "09596658",
            "lastpage": "62",
            "pmid": "26353918",
            "pub_year": 2015,
            "title": "Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli",
            "volume": "26"
        },
        "b0375": {
            "authors": [
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wacker"
                }
            ],
            "doi": "10.1093/infdis/jiv429",
            "firstpage": "6",
            "issn": "00221899",
            "lastpage": "13",
            "pmid": "26333944",
            "pub_year": 2016,
            "title": "Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field",
            "volume": "213"
        },
        "b0380": {
            "authors": [
                {
                    "first": "Victoria L.",
                    "initial": "V.L.",
                    "last": "Campod\u00f3nico"
                },
                {
                    "first": "Nicolas J.",
                    "initial": "N.J.",
                    "last": "Llosa"
                },
                {
                    "first": "Leticia V.",
                    "initial": "L.V.",
                    "last": "Bentancor"
                },
                {
                    "first": "Tomas",
                    "initial": "T.",
                    "last": "Maira-Litran"
                },
                {
                    "first": "Gerald B.",
                    "initial": "G.B.",
                    "last": "Pier"
                }
            ],
            "doi": "10.1128/IAI.00157-11",
            "firstpage": "3455",
            "issn": "00199567",
            "lastpage": "3464",
            "pmid": "21628521",
            "pub_year": 2011,
            "title": "Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice",
            "volume": "79"
        },
        "b0385": {
            "authors": [
                {
                    "first": "Danka",
                    "initial": "D.",
                    "last": "Pavliakova"
                },
                {
                    "first": "J. Scott",
                    "initial": "J.S.",
                    "last": "Moncrief"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Lyerly"
                },
                {
                    "first": "Gerald",
                    "initial": "G.",
                    "last": "Schiffman"
                },
                {
                    "first": "Dolores A.",
                    "initial": "D.A.",
                    "last": "Bryla"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                }
            ],
            "doi": "10.1128/IAI.68.4.2161-2166.2000",
            "firstpage": "2161",
            "issn": "00199567",
            "lastpage": "2166",
            "pmid": "10722615",
            "pub_year": 2000,
            "title": "Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice",
            "volume": "68"
        },
        "b0390": {
            "authors": [
                {
                    "first": "Maria R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Rosanna",
                    "initial": "R.",
                    "last": "Leuzzi"
                },
                {
                    "first": "Emilia",
                    "initial": "E.",
                    "last": "Cappelletti"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Nilo"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Costantino"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Scarselli"
                }
            ],
            "doi": "10.3390/toxins6041385",
            "firstpage": "1385",
            "issn": "20726651",
            "lastpage": "1396",
            "pmid": "24759173",
            "pub_year": 2014,
            "title": "Recombinant clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity",
            "volume": "6"
        },
        "b0395": {
            "authors": [
                {
                    "first": "Karen M.",
                    "initial": "K.M.",
                    "last": "Edmond"
                },
                {
                    "first": "Christina",
                    "initial": "C.",
                    "last": "Kortsalioudaki"
                },
                {
                    "first": "Susana",
                    "initial": "S.",
                    "last": "Scott"
                },
                {
                    "first": "Stephanie J.",
                    "initial": "S.J.",
                    "last": "Schrag"
                },
                {
                    "first": "Anita Km",
                    "initial": "A.K.",
                    "last": "Zaidi"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Cousens"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Heath"
                }
            ],
            "doi": "10.1016/S0140-6736(11)61651-6",
            "firstpage": "547",
            "issn": "01406736",
            "lastpage": "556",
            "pmid": "22226047",
            "pub_year": 2012,
            "title": "Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis",
            "volume": "379"
        },
        "b0400": {
            "authors": [
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Nilo"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Allan"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Brogioni"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "Vittorio",
                    "initial": "V.",
                    "last": "Cattaneo"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Crotti"
                },
                {
                    "first": "Samantha",
                    "initial": "S.",
                    "last": "Sokup"
                },
                {
                    "first": "Huili",
                    "initial": "H.",
                    "last": "Zhai"
                },
                {
                    "first": "Immaculada",
                    "initial": "I.",
                    "last": "Margarit"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Qi Ying",
                    "initial": "Q.Y.",
                    "last": "Hu"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                }
            ],
            "doi": "10.1021/bc500438h",
            "firstpage": "2105",
            "issn": "10431802",
            "lastpage": "2111",
            "pmid": "25415860",
            "pub_year": 2014,
            "title": "Tyrosine-directed conjugation of large glycans to proteins via copper-free click chemistry",
            "volume": "25"
        },
        "b0405": {
            "authors": [
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Nilo"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Morelli"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "Passalacqua"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Brogioni"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Allan"
                },
                {
                    "first": "Filippo",
                    "initial": "F.",
                    "last": "Carboni"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Pezzicoli"
                },
                {
                    "first": "Francesca",
                    "initial": "F.",
                    "last": "Zerbini"
                },
                {
                    "first": "Domenico",
                    "initial": "D.",
                    "last": "Maione"
                },
                {
                    "first": "Monica",
                    "initial": "M.",
                    "last": "Fabbrini"
                },
                {
                    "first": "Maria Rosaria",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Qi Ying",
                    "initial": "Q.Y.",
                    "last": "Hu"
                },
                {
                    "first": "Immaculada",
                    "initial": "I.",
                    "last": "Margarit"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                }
            ],
            "doi": "10.1021/acschembio.5b00247",
            "firstpage": "1737",
            "issn": "15548929",
            "lastpage": "1746",
            "pmid": "25906283",
            "pub_year": 2015,
            "title": "Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation",
            "volume": "10"
        },
        "b0410": {
            "authors": [
                {
                    "first": "Domenico",
                    "initial": "D.",
                    "last": "Maione"
                },
                {
                    "first": "Immaculada",
                    "initial": "I.",
                    "last": "Margarit"
                },
                {
                    "first": "Cira D.",
                    "initial": "C.D.",
                    "last": "Rinaudo"
                },
                {
                    "first": "Vega",
                    "initial": "V.",
                    "last": "Masignani"
                },
                {
                    "first": "Marirosa",
                    "initial": "M.",
                    "last": "Mora"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Scarselli"
                },
                {
                    "first": "Herv\u00e9",
                    "initial": "H.",
                    "last": "Tettelin"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Brettoni"
                },
                {
                    "first": "Emilia T.",
                    "initial": "E.T.",
                    "last": "Iacobini"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Rosini"
                },
                {
                    "first": "Nunzio",
                    "initial": "N.",
                    "last": "D'Agostino"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Miorin"
                },
                {
                    "first": "Scilla",
                    "initial": "S.",
                    "last": "Buccato"
                },
                {
                    "first": "Massimo",
                    "initial": "M.",
                    "last": "Mariani"
                },
                {
                    "first": "Giuliano",
                    "initial": "G.",
                    "last": "Galli"
                },
                {
                    "first": "Renzo",
                    "initial": "R.",
                    "last": "Nogarotto"
                },
                {
                    "first": "Vincenzo Nardi",
                    "initial": "V.N.",
                    "last": "Dei"
                },
                {
                    "first": "Filipo",
                    "initial": "F.",
                    "last": "Vegni"
                },
                {
                    "first": "Claire",
                    "initial": "C.",
                    "last": "Fraser"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Mancuso"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Teti"
                },
                {
                    "first": "Lawrence C.",
                    "initial": "L.C.",
                    "last": "Madoff"
                },
                {
                    "first": "Lawrence C.",
                    "initial": "L.C.",
                    "last": "Paoletti"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Dennis L.",
                    "initial": "D.L.",
                    "last": "Kasper"
                },
                {
                    "first": "John L.",
                    "initial": "J.L.",
                    "last": "Telford"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Grandi"
                }
            ],
            "doi": "10.1126/science.1109869",
            "firstpage": "148",
            "issn": "00368075",
            "lastpage": "150",
            "pmid": "15994562",
            "pub_year": 2005,
            "title": "Immunology: Identification of a universal group B Streptococcus vaccine by multiple genome screen",
            "volume": "309"
        },
        "b0415": {
            "authors": [
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Nilo"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "Passalacqua"
                },
                {
                    "first": "Monica",
                    "initial": "M.",
                    "last": "Fabbrini"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Allan"
                },
                {
                    "first": "Aimee",
                    "initial": "A.",
                    "last": "Usera"
                },
                {
                    "first": "Filippo",
                    "initial": "F.",
                    "last": "Carboni"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Brogioni"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Pezzicoli"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Cobb"
                },
                {
                    "first": "Maria Rosaria",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "Immaculada",
                    "initial": "I.",
                    "last": "Margarit"
                },
                {
                    "first": "Qi Ying",
                    "initial": "Q.Y.",
                    "last": "Hu"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Adamo"
                }
            ],
            "doi": "10.1021/acs.bioconjchem.5b00365",
            "firstpage": "1839",
            "issn": "10431802",
            "lastpage": "1849",
            "pmid": "26230938",
            "pub_year": 2015,
            "title": "Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type v Polysaccharide",
            "volume": "26"
        },
        "b0420": {
            "authors": [
                {
                    "first": "Kristin",
                    "initial": "K.",
                    "last": "Moffitt"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Malley"
                }
            ],
            "doi": "10.1080/21645515.2015.1087625",
            "firstpage": "383",
            "issn": "21645515",
            "lastpage": "392",
            "pmid": "26535755",
            "pub_year": 2016,
            "title": "Rationale and prospects for novel pneumococcal vaccines",
            "volume": "12"
        },
        "b0425": {
            "authors": [
                {
                    "first": "Catia T.",
                    "initial": "C.T.",
                    "last": "Perciani"
                },
                {
                    "first": "Giovana C.",
                    "initial": "G.C.",
                    "last": "Barazzone"
                },
                {
                    "first": "Cibelly",
                    "initial": "C.",
                    "last": "Goulart"
                },
                {
                    "first": "Eneas",
                    "initial": "E.",
                    "last": "Carvalho"
                },
                {
                    "first": "Joaquin",
                    "initial": "J.",
                    "last": "Cabrera-Crespo"
                },
                {
                    "first": "Viviane M.",
                    "initial": "V.M.",
                    "last": "Gon\u00e7alves"
                },
                {
                    "first": "Luciana C.C.",
                    "initial": "L.C.C.",
                    "last": "Leite"
                },
                {
                    "first": "Martha M.",
                    "initial": "M.M.",
                    "last": "Tanizaki"
                }
            ],
            "doi": "10.1128/CVI.00754-12",
            "firstpage": "818",
            "issn": "15566811",
            "lastpage": "826",
            "pmid": "23554468",
            "pub_year": 2013,
            "title": "Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response",
            "volume": "20"
        },
        "b0430": {
            "authors": [
                {
                    "first": "Raquel",
                    "initial": "R.",
                    "last": "Santamaria"
                },
                {
                    "first": "Cibelly",
                    "initial": "C.",
                    "last": "Goulart"
                },
                {
                    "first": "Catia T.",
                    "initial": "C.T.",
                    "last": "Perciani"
                },
                {
                    "first": "Giovana C.",
                    "initial": "G.C.",
                    "last": "Barazzone"
                },
                {
                    "first": "Rimenys J.",
                    "initial": "R.J.",
                    "last": "Carvalho"
                },
                {
                    "first": "Viviane M.",
                    "initial": "V.M.",
                    "last": "Gon\u00e7alves"
                },
                {
                    "first": "Luciana C.C.",
                    "initial": "L.C.C.",
                    "last": "Leite"
                },
                {
                    "first": "Martha M.",
                    "initial": "M.M.",
                    "last": "Tanizaki"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.08.109",
            "firstpage": "8689",
            "issn": "0264410X",
            "lastpage": "8695",
            "pmid": "21906649",
            "pub_year": 2011,
            "title": "Humoral immune response of a pneumococcal conjugate vaccine: Capsular polysaccharide serotype 14-Lysine modified PspA",
            "volume": "29"
        },
        "b0435": {
            "authors": [
                {
                    "first": "Karlis",
                    "initial": "K.",
                    "last": "Pauksens"
                },
                {
                    "first": "Anna C.",
                    "initial": "A.C.",
                    "last": "Nilsson"
                },
                {
                    "first": "Magalie",
                    "initial": "M.",
                    "last": "Caubet"
                },
                {
                    "first": "Thierry G.",
                    "initial": "T.G.",
                    "last": "Pascal"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "Pierre G.",
                    "initial": "P.G.",
                    "last": "Vandepapeli\u00e8re"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Peter E.",
                    "initial": "P.E.",
                    "last": "Vink"
                }
            ],
            "doi": "10.1128/CVI.00807-13",
            "firstpage": "651",
            "issn": "15566811",
            "lastpage": "660",
            "pmid": "24599529",
            "pub_year": 2014,
            "title": "Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02Vin elderly adults",
            "volume": "21"
        },
        "b0440": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tontini"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Romano"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Proietti"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Balducci"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Micoli"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Balocchi"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Santini"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Masignani"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Berti"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Costantino"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.06.039",
            "firstpage": "4235",
            "issn": "0264410X",
            "lastpage": "4242",
            "pmid": "27317455",
            "pub_year": 2016,
            "title": "Preclinical studies on new proteins as carrier for glycoconjugate vaccines",
            "volume": "34"
        },
        "b0445": {
            "authors": [
                {
                    "first": "Fabio",
                    "initial": "F.",
                    "last": "Bagnoli"
                },
                {
                    "first": "Sylvie",
                    "initial": "S.",
                    "last": "Bertholet"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Grandi"
                }
            ],
            "firstpage": "16",
            "issn": "22352988",
            "pmid": "22919608",
            "pub_year": 2012,
            "title": "Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.",
            "volume": "2"
        },
        "b0450": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Wacker"
                },
                {
                    "first": "Linhui",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Kowarik"
                },
                {
                    "first": "Meghan",
                    "initial": "M.",
                    "last": "Dowd"
                },
                {
                    "first": "Gerd",
                    "initial": "G.",
                    "last": "Lipowsky"
                },
                {
                    "first": "Amir",
                    "initial": "A.",
                    "last": "Faridmoayer"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Shields"
                },
                {
                    "first": "Saeyoung",
                    "initial": "S.",
                    "last": "Park"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Alaimo"
                },
                {
                    "first": "Kathryn A.",
                    "initial": "K.A.",
                    "last": "Kelley"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Braun"
                },
                {
                    "first": "Julien",
                    "initial": "J.",
                    "last": "Quebatte"
                },
                {
                    "first": "Veronica",
                    "initial": "V.",
                    "last": "Gambillara"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Carranza"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Steffen"
                },
                {
                    "first": "Jean C.",
                    "initial": "J.C.",
                    "last": "Lee"
                }
            ],
            "doi": "10.1093/infdis/jit800",
            "firstpage": "1551",
            "issn": "00221899",
            "lastpage": "1561",
            "pmid": "24308931",
            "pub_year": 2014,
            "title": "Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli",
            "volume": "209"
        },
        "b0455": {
            "authors": [
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Konadu"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Donohue-Rolfe"
                },
                {
                    "first": "Stephen B.",
                    "initial": "S.B.",
                    "last": "Calderwood"
                },
                {
                    "first": "Vince",
                    "initial": "V.",
                    "last": "Pozsgay"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Shiloach"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Shousun C.",
                    "initial": "S.C.",
                    "last": "Szu"
                }
            ],
            "firstpage": "6191",
            "issn": "00199567",
            "lastpage": "6193",
            "pmid": "10531288",
            "pub_year": 1999,
            "title": "Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice",
            "volume": "67"
        },
        "b0460": {
            "authors": [
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "Lua"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Skurnik"
                },
                {
                    "first": "Clarissa",
                    "initial": "C.",
                    "last": "Pozzi"
                },
                {
                    "first": "Damien",
                    "initial": "D.",
                    "last": "Roux"
                },
                {
                    "first": "Colette",
                    "initial": "C.",
                    "last": "Cywes-Bentley"
                },
                {
                    "first": "Jennifer M.",
                    "initial": "J.M.",
                    "last": "Ritchie"
                },
                {
                    "first": "Diana",
                    "initial": "D.",
                    "last": "Munera"
                },
                {
                    "first": "Marina L.",
                    "initial": "M.L.",
                    "last": "Gening"
                },
                {
                    "first": "Yury E.",
                    "initial": "Y.E.",
                    "last": "Tsvetkov"
                },
                {
                    "first": "Nikolay E.",
                    "initial": "N.E.",
                    "last": "Nifantiev"
                },
                {
                    "first": "Matthew K.",
                    "initial": "M.K.",
                    "last": "Waldor"
                },
                {
                    "first": "Gerald B.",
                    "initial": "G.B.",
                    "last": "Pier"
                }
            ],
            "doi": "10.1128/mBio.00974-14",
            "issn": "21612129",
            "pmid": "24667709",
            "pub_year": 2014,
            "title": "A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli",
            "volume": "5"
        },
        "b0465": {
            "authors": [
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Brett"
                },
                {
                    "first": "Donald E.",
                    "initial": "D.E.",
                    "last": "Woods"
                }
            ],
            "firstpage": "2824",
            "issn": "00199567",
            "lastpage": "2828",
            "pmid": "8698517",
            "pub_year": 1996,
            "title": "Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates",
            "volume": "64"
        }
    },
    "body_text": [
        {
            "endOffset": 19785,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 19784,
                    "startOffset": 19777
                },
                "b0055": {
                    "endOffset": 19784,
                    "startOffset": 19777
                },
                "b0060": {
                    "endOffset": 19784,
                    "startOffset": 19777
                }
            },
            "secId": "s0020",
            "sentence": "Three randomized controlled trials (RCTs) have compared capsular groups A, C, W, Y meningococcal conjugate vaccine (MenACWY_TT) with MenACWY non-conjugated vaccine in adolescents/adults (mostly previously immunized against tetanus) [10\u201312].",
            "startOffset": 19545,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 33094,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0250": {
                    "endOffset": 33093,
                    "startOffset": 33089
                }
            },
            "secId": "s0050",
            "sentence": "This carrier boosts the immune response to Hib, significantly more so than DT or TT carriers after one or two doses [50].",
            "startOffset": 32973,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 40728,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0425": {
                    "endOffset": 40629,
                    "startOffset": 40625
                },
                "b0430": {
                    "endOffset": 40727,
                    "startOffset": 40723
                }
            },
            "secId": "s0090",
            "sentence": "In mice, conjugation of S. pneumoniae capsular polysaccharide serotype 6B to recombinant PspA induced functional antibodies to serotype 6B and the PspA carrier [85]; and conjugation of serotype 14 to modified PspA improved the immune response to serotype 14 [86].",
            "startOffset": 40465,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 26172,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0035",
            "sentence": "All subjects had protective levels (\u22650.1 IU/mL) prior to vaccination as they had previously received vaccinations against tetanus and diphtheria, so this study showed boosting of TT and DT levels with the conjugate vaccine.",
            "startOffset": 25949,
            "title": "Mixed TT and DT carrier proteins"
        },
        {
            "endOffset": 24880,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "This study showed a benefit of diphtheria boosting from MenC_CRM, although it is surprising that 51% of 4-year-olds who had not received MenC_CRM were seemingly not protected against diphtheria despite routine infant vaccination.",
            "startOffset": 24651,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 44203,
            "parents": [],
            "secId": "s0115",
            "sentence": "All authors reviewed the literature, provided substantial input, contributed to writing, and reviewed the paper.",
            "startOffset": 44091,
            "title": "Contributorship"
        },
        {
            "endOffset": 27759,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0040",
            "sentence": "Such tests are regarded as predictive for protection by non-conjugated tetanus and diphtheria vaccines in humans, so should also be predictive for conjugated toxoids.",
            "startOffset": 27593,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 17373,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 17339,
                    "startOffset": 17336
                }
            },
            "secId": "s0005",
            "sentence": "Repeated doses do not seem to be beneficial, and may result in lower antibody concentrations than those after primary immunization [3], so-called \u201chypo-responsiveness\u201d.",
            "startOffset": 17205,
            "title": "Introduction"
        },
        {
            "endOffset": 29550,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 29549,
                    "startOffset": 29545
                }
            },
            "secId": "s0045",
            "sentence": "However, a recent mouse study reported that PHiD-CV elicited antibodies against protein D, but not whole NTHi, and pulmonary clearance of NTHi was not augmented [35].",
            "startOffset": 29384,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 23539,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 23436,
                    "startOffset": 23432
                }
            },
            "secId": "s0030",
            "sentence": "In one study [21], infants received DTaP-IPV-Hib with either MenC_CRM or hepatitis B vaccine at ages 2, 4, and 6 months.",
            "startOffset": 23419,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 21094,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 21093,
                    "startOffset": 21089
                }
            },
            "secId": "s0020",
            "sentence": "Although there was no difference in tetanus-specific IgG antibody levels before and after MenC_TT introduction among children aged < 9 years, older children (who had received diphtheria-tetanus-IPV at age 9 years) had higher tetanus-specific IgG antibody levels after vs. before MenC_TT introduction [14].",
            "startOffset": 20789,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 25948,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 25947,
                    "startOffset": 25943
                }
            },
            "secId": "s0035",
            "sentence": "In a study of an 11-valent pneumococcal conjugate vaccine (PCV) in which the polysaccharides of seven pneumococcal serotypes were conjugated to TT and those of four to DT, there were significant 4\u201346- and 7\u201329-fold increases in TT and DT GMCs, respectively [25].",
            "startOffset": 25686,
            "title": "Mixed TT and DT carrier proteins"
        },
        {
            "endOffset": 23715,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 23714,
                    "startOffset": 23710
                }
            },
            "secId": "s0030",
            "sentence": "At age 7 months, those who had received MenC_CRM had higher GMC diphtheria antibody titers than those who had received hepatitis B vaccine (4.7 vs. 1.9 IU/mL; p < 0.001) [21].",
            "startOffset": 23540,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 45211,
            "parents": [],
            "secId": "s0130",
            "sentence": "Hiberix, Menitorix, MenHibrix, VaxemHib, Menjugate, Menveo, and Synflorix are trademarks of the GSK group of companies.",
            "startOffset": 45092,
            "title": "Declaration"
        },
        {
            "endOffset": 31347,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0230": {
                    "endOffset": 31219,
                    "startOffset": 31215
                }
            },
            "secId": "s0045",
            "sentence": "A significant reduction in suppurative otitis media was observed with PHiD-CV vs. PCV7_CRM/PPV23 (39% vs. 51%; p = 0.0004) [46], along with a significant reduction in NTHi-infected ear discharge (Fig. 3A), but no reduction in NTHi nasopharyngeal carriage.",
            "startOffset": 31092,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 43574,
            "parents": [],
            "secId": "s0110",
            "sentence": "This could be ameliorated by using novel carriers.",
            "startOffset": 43524,
            "title": "Conclusions"
        },
        {
            "endOffset": 18400,
            "parents": [],
            "secId": "s0005",
            "sentence": "Hence, the aims of this review are to provide information on current and novel protein carriers and discuss the potential implications of this \u201cneglected valency\u201d.",
            "startOffset": 18237,
            "title": "Introduction"
        },
        {
            "endOffset": 26976,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 26975,
                    "startOffset": 26971
                }
            },
            "secId": "s0040",
            "sentence": "Infant tetanus and diphtheria immune responses to three different MenC vaccines (one conjugated to TT and two to CRM) when concomitantly administered with a 7-valent PCV conjugated to CRM (PCV7_CRM) and DTaP-IPV-Hib_TT has been analyzed in an RCT [27].",
            "startOffset": 26724,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 40240,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0420": {
                    "endOffset": 40239,
                    "startOffset": 40235
                }
            },
            "secId": "s0090",
            "sentence": "Although multivalent PCVs have successfully reduced vaccine-type invasive pneumococcal disease, non-vaccine serotypes are still causing disease, resulting in the development of vaccines with broader coverage [84].",
            "startOffset": 40027,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 44843,
            "parents": [],
            "secId": "s0120",
            "sentence": "JS is an employee and shareholder of LimmaTech Biologics AG, a company acquired and funded by GSK to develop in vivo bioconjugation technology.",
            "startOffset": 44700,
            "title": "Disclosures"
        },
        {
            "endOffset": 21833,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0025",
            "sentence": "Diphtheria toxin, which causes the clinical manifestations of diphtheria, can be chemically inactivated to diphtheria toxoid (DT).",
            "startOffset": 21703,
            "title": "Diphtheria toxoid"
        },
        {
            "endOffset": 18191,
            "parents": [],
            "secId": "s0005",
            "sentence": "Conjugate vaccines may, therefore, induce immunity against the pathogen from which the carrier protein is derived \u2013 a potential \u201cadditional valency\u201d.",
            "startOffset": 18042,
            "title": "Introduction"
        },
        {
            "endOffset": 30777,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0200": {
                    "endOffset": 30626,
                    "startOffset": 30619
                },
                "b0205": {
                    "endOffset": 30626,
                    "startOffset": 30619
                },
                "b0210": {
                    "endOffset": 30626,
                    "startOffset": 30619
                },
                "b0215": {
                    "endOffset": 30704,
                    "startOffset": 30700
                }
            },
            "secId": "s0045",
            "sentence": "However, other RCTs have shown no consistent impact of PHiD-CV on NTHi nasopharyngeal colonization [40\u201342]; and a pre-/post-PHiD-CV introduction study noted a significant increase [43], which could have been due to seasonal differences in sample collection.",
            "startOffset": 30520,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 36088,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0300": {
                    "endOffset": 36087,
                    "startOffset": 36080
                },
                "b0305": {
                    "endOffset": 36087,
                    "startOffset": 36080
                },
                "b0310": {
                    "endOffset": 36087,
                    "startOffset": 36080
                }
            },
            "secId": "s0075",
            "sentence": "Various modifications of exotoxin A of P. aeruginosa (EPA) have been tested as vaccine antigens in animal studies [60\u201362].",
            "startOffset": 35966,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 35903,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0065",
            "sentence": "Some potential new alternatives are discussed below.",
            "startOffset": 35851,
            "title": "Potential limitations"
        },
        {
            "endOffset": 44076,
            "parents": [],
            "secId": "s0110",
            "sentence": "If sufficient data can be accumulated, this could eventually lead to additional advantages in the protection afforded in current and future immunization schedules.",
            "startOffset": 43913,
            "title": "Conclusions"
        },
        {
            "endOffset": 40011,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "The random GBS type V_GBS67 performed similarly to GBS type V_CRM.",
            "startOffset": 39945,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 31823,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0045",
            "sentence": "However, this added protection is not complete and use of several different NTHi proteins might improve this.",
            "startOffset": 31714,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 25522,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "Significantly more subjects who had vs. not already received the CRM-conjugated vaccines had anti-diphtheria IgG \u2265 0.1 IU/mL prior to Tdap (95% vs. 60%; p < 0.01).",
            "startOffset": 25359,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 23935,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 23832,
                    "startOffset": 23828
                }
            },
            "secId": "s0030",
            "sentence": "In another study [22], adolescents received Tdap and human papillomavirus vaccine concomitantly with MenACWY_CRM or placebo.",
            "startOffset": 23811,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 44699,
            "parents": [],
            "secId": "s0120",
            "sentence": "FB has a patent GBS Pilus protein polysaccharide conjugates pending.",
            "startOffset": 44631,
            "title": "Disclosures"
        },
        {
            "endOffset": 21940,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0025",
            "sentence": "This is used in vaccines against diphtheria and as a protein carrier in polysaccharide vaccines (Table 1).",
            "startOffset": 21834,
            "title": "Diphtheria toxoid"
        },
        {
            "endOffset": 39849,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "All site-specific glycoconjugates induced good antibody levels against the polysaccharide and protein portions and opsonophagocytic killing.",
            "startOffset": 39709,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 20043,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 20042,
                    "startOffset": 20035
                },
                "b0055": {
                    "endOffset": 20042,
                    "startOffset": 20035
                },
                "b0060": {
                    "endOffset": 20042,
                    "startOffset": 20035
                }
            },
            "secId": "s0020",
            "sentence": "These only showed booster TT immune responses to the conjugated vaccine (14\u201328-fold vs. no increase in anti-TT geometric mean concentrations [GMCs]; increase in subjects with anti-tetanus antibodies \u22650.1 IU/mL from 52\u201367% to 79\u201398% vs. no increase) [10\u201312].",
            "startOffset": 19786,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 24290,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 24189,
                    "startOffset": 24185
                }
            },
            "secId": "s0030",
            "sentence": "McVernon et al. [23] studied the persistence of diphtheria antibodies in 4-year-olds before and after a MenC_CRM booster.",
            "startOffset": 24169,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 32464,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 32463,
                    "startOffset": 32459
                }
            },
            "secId": "s0050",
            "sentence": "Traditional capsular group B meningococcal (MenB) outer membrane vesicle vaccines contain Porin A \u2013 one of the main, but highly variable, components of OMPC \u2013 as the most immunogenic antigen conferring protection against invasive meningococcal disease [47].",
            "startOffset": 32207,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 19545,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0020",
            "sentence": "All had seroprotective TT antibodies (\u22650.01 U/mL) before and after immunization.",
            "startOffset": 19465,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 38600,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0395": {
                    "endOffset": 38599,
                    "startOffset": 38595
                }
            },
            "secId": "s0085",
            "sentence": "Immunization of pregnant women with a 5-valent GBS polysaccharide conjugate vaccine against serotypes Ia, Ib, II, III, and V is expected to cover > 90% of infant serotypes in Europe and the US [79].",
            "startOffset": 38402,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 23004,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 23003,
                    "startOffset": 22996
                },
                "b0095": {
                    "endOffset": 23003,
                    "startOffset": 22996
                }
            },
            "secId": "s0030",
            "sentence": "Cross-reacting material 197 (CRM) is a non-toxic mutant (single amino acid substitution) of diphtheria toxin that does not need deactivating, making it a more homogeneous product than DT [18,19].",
            "startOffset": 22809,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 42574,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0100",
            "sentence": "PNAG and Shiga toxin 1b antibodies were produced; the latter neutralized Shiga toxin 1 potently (and Shiga toxin 2 modestly).",
            "startOffset": 42449,
            "title": "E. coli"
        },
        {
            "endOffset": 37561,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0385": {
                    "endOffset": 37560,
                    "startOffset": 37556
                }
            },
            "secId": "s0080",
            "sentence": "A nontoxic peptide from C. difficile toxin A (CDTA) has been covalently bound to the surface polysaccharides of pneumococcus type 14, Shigella flexneri type 2a, and E. coli K1 [77].",
            "startOffset": 37380,
            "title": "Costridium difficile"
        },
        {
            "endOffset": 28933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0045",
            "sentence": "Protein D, which is expressed by H. influenzae, was used in PHiD-CV with the aim to provide protection against NTHi acute otitis media (AOM) and reduce the potential for interference between vaccines with the same carrier.",
            "startOffset": 28711,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 44326,
            "parents": [],
            "secId": "s0115",
            "sentence": "All authors approved the final article and are accountable for all aspects of the work.",
            "startOffset": 44239,
            "title": "Contributorship"
        },
        {
            "endOffset": 27592,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 27591,
                    "startOffset": 27587
                }
            },
            "secId": "s0040",
            "sentence": "In a study in immunologically na\u00efve animals, TT and DT carriers induced protective immune responses against lethal challenges of tetanus and diphtheria toxins, respectively, but this was not so for CRM against diphtheria toxin [28].",
            "startOffset": 27360,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 21519,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 21518,
                    "startOffset": 21514
                }
            },
            "secId": "s0020",
            "sentence": "Among African meningitis belt countries with MenA_TT campaigns covering the whole country, neonatal tetanus cases fell by 25.4%, compared with a 14.4% increase in countries without such campaigns [15].",
            "startOffset": 21318,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 20788,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 20787,
                    "startOffset": 20783
                }
            },
            "secId": "s0020",
            "sentence": "A sero-epidemiological study has compared tetanus-specific immunoglobulin G (IgG) antibody levels before and after the introduction of a national capsular group C meningococcal conjugate vaccine (MenC_TT) program [14].",
            "startOffset": 20570,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 28710,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 28699,
                    "startOffset": 28695
                }
            },
            "secId": "s0045",
            "sentence": "PCV7 and PCV13 both use CRM carriers, but in the 10-valent vaccine (non-typeable H. influenzae [NTHi] protein D conjugate vaccine [PHiD-CV]), one pneumococcal serotype is conjugated to TT, one to DT, and eight to protein D [30] (Table 1).",
            "startOffset": 28472,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 25054,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 25053,
                    "startOffset": 25049
                }
            },
            "secId": "s0030",
            "sentence": "Another study randomized adults to 13-valent pneumococcal conjugate vaccine (PCV13_CRM) plus MenACWY_CRM 3\u20134 weeks before, at the same time as, or 3\u20134 weeks after Tdap [24].",
            "startOffset": 24881,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 34587,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 34569,
                    "startOffset": 34562
                },
                "b0275": {
                    "endOffset": 34569,
                    "startOffset": 34562
                },
                "b0280": {
                    "endOffset": 34586,
                    "startOffset": 34582
                }
            },
            "secId": "s0065",
            "sentence": "Co-administration can occur with sequential or concurrent vaccinations, and be either positive [27,55] or negative [56].",
            "startOffset": 34467,
            "title": "Potential limitations"
        },
        {
            "endOffset": 26723,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 26722,
                    "startOffset": 26718
                }
            },
            "secId": "s0040",
            "sentence": "Prior to their 12\u201315-month boosters, tetanus antibody levels were 2.7-fold higher among those who had received Hib-MenC_TT vs. MenC_CRM and 97% vs. 79% had protective levels (\u22650.1 IU/mL); diphtheria antibody levels were 2.8-fold higher among those who had received MenC_CRM vs. Hib-MenC_TT and 89% vs. 45% had protective levels (\u22650.1 IU/mL) (all significant) [26].",
            "startOffset": 26359,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 39433,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "After incubation of the sera with GBS type V, all sera resulted in GBS opsonophagocytosis and killing, with the greatest effect when all four antigens were used together.",
            "startOffset": 39263,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 22808,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22807,
                    "startOffset": 22803
                }
            },
            "secId": "s0030",
            "sentence": "Chemical inactivation of diphtheria toxin to DT gives a heterogeneous mixture [18].",
            "startOffset": 22725,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 44238,
            "parents": [],
            "secId": "s0115",
            "sentence": "MB led the manuscript development.",
            "startOffset": 44204,
            "title": "Contributorship"
        },
        {
            "endOffset": 17946,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 17760,
                    "startOffset": 17757
                },
                "b0025": {
                    "endOffset": 17662,
                    "startOffset": 17657
                },
                "b0030": {
                    "endOffset": 17662,
                    "startOffset": 17657
                },
                "b0035": {
                    "endOffset": 17662,
                    "startOffset": 17657
                }
            },
            "secId": "s0005",
            "sentence": "While the mechanisms for this are not fully understood [5\u20137], polysaccharide conjugate vaccines have several advantages over plain polysaccharide vaccines [2]: induction of higher antibody concentrations, for a longer time; high immunogenicity in young children; and repeated doses boost the immune response without causing hypo-responsiveness.",
            "startOffset": 17602,
            "title": "Introduction"
        },
        {
            "endOffset": 18723,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this review, an underscore between polysaccharide antigen and carrier protein identifies a conjugate (e.g. Haemophilus influenzae type b conjugated to tetanus toxoid = Hib_TT), while a hyphen indicates a combination of antigens (e.g. diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Hib = DTaP-IPV-Hib).",
            "startOffset": 18400,
            "title": "Introduction"
        },
        {
            "endOffset": 35552,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0065",
            "sentence": "As these immune interference effects are difficult to predict, studies to assess such interactions are needed.",
            "startOffset": 35442,
            "title": "Potential limitations"
        },
        {
            "endOffset": 21681,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0020",
            "sentence": "The TT conjugates in MenA_TT vaccines given to women may therefore provide concomitant tetanus protection for their neonates, although further study is required.",
            "startOffset": 21520,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 42995,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0105",
            "sentence": "This IgG was protective against challenge with a heterologous strain of B. pseudomallei.",
            "startOffset": 42907,
            "title": "Burkholderia pseudomallei"
        },
        {
            "endOffset": 29032,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 29031,
                    "startOffset": 29027
                }
            },
            "secId": "s0045",
            "sentence": "Various animal studies have shown immunogenicity of protein D, as reviewed by Forsgren et al. [31].",
            "startOffset": 28933,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 23418,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 23417,
                    "startOffset": 23410
                },
                "b0110": {
                    "endOffset": 23417,
                    "startOffset": 23410
                }
            },
            "secId": "s0030",
            "sentence": "Concomitant administration of CRM-conjugated vaccines can increase the diphtheria immune response after diphtheria vaccination [21,22].",
            "startOffset": 23283,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 45091,
            "parents": [],
            "secId": "s0130",
            "sentence": "Descriptions of the vaccine profiles made in the paper may not be covered within the summaries of product characteristics.",
            "startOffset": 44969,
            "title": "Declaration"
        },
        {
            "endOffset": 24518,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "Children who received four doses of MenC_CRM during infancy had higher diphtheria GMCs than those who received no doses, both before (0.35 vs. 0.10 IU/mL; p < 0.001) and after the booster (9.00 vs. 4.55 IU/mL; not significant).",
            "startOffset": 24291,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 36321,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0315": {
                    "endOffset": 36222,
                    "startOffset": 36215
                },
                "b0320": {
                    "endOffset": 36222,
                    "startOffset": 36215
                },
                "b0325": {
                    "endOffset": 36222,
                    "startOffset": 36215
                },
                "b0330": {
                    "endOffset": 36222,
                    "startOffset": 36215
                },
                "b0335": {
                    "endOffset": 36248,
                    "startOffset": 36241
                },
                "b0340": {
                    "endOffset": 36248,
                    "startOffset": 36241
                },
                "b0345": {
                    "endOffset": 36280,
                    "startOffset": 36276
                },
                "b0350": {
                    "endOffset": 36319,
                    "startOffset": 36312
                },
                "b0355": {
                    "endOffset": 36319,
                    "startOffset": 36312
                },
                "b0360": {
                    "endOffset": 36319,
                    "startOffset": 36312
                }
            },
            "secId": "s0075",
            "sentence": "A number of polysaccharides have been conjugated to EPA and tested in animals and humans, both heterovalent (Escherichia coli [63\u201366], Salmonella typhi [67,68], and Staphylococcus aureus [69]) and homovalent (P. aeruginosa [70\u201372]).",
            "startOffset": 36089,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 39708,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "Control vaccines had random conjugation to GBS67 or CRM.",
            "startOffset": 39652,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 40465,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0090",
            "sentence": "Proposed options include the use of protective pneumococcal proteins as antigens and carriers, e.g. pneumococcal surface protein A (PspA), pneumococcal histidine triad D (PhtD), detoxified pneumolysin (dPly), and spr96/2021.",
            "startOffset": 40241,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 31619,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0045",
            "sentence": "However, further studies are required to ascertain whether these observations are extrapolatable to other populations.",
            "startOffset": 31501,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 42906,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0465": {
                    "endOffset": 42905,
                    "startOffset": 42901
                }
            },
            "secId": "s0105",
            "sentence": "A conjugate of two B. pseudomallei 319a components \u2013 an O-polysaccharide moiety and flagellin protein \u2013 resulted in high IgG titers to both components in an animal model [93].",
            "startOffset": 42731,
            "title": "Burkholderia pseudomallei"
        },
        {
            "endOffset": 43912,
            "parents": [],
            "secId": "s0110",
            "sentence": "While data clearly show the potential protection of carrier proteins, each vaccine is different, so any protective \u201cadditional valency\u201d effect needs to be characterized for each vaccine.",
            "startOffset": 43726,
            "title": "Conclusions"
        },
        {
            "endOffset": 29834,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 29833,
                    "startOffset": 29829
                }
            },
            "secId": "s0045",
            "sentence": "The (never-licensed) 11-valent predecessor to PHiD-CV (all serotypes conjugated to protein D) had efficacy against NTHi AOM in an RCT (primary endpoint: first AOM episode) against a hepatitis A control vaccine (35.3%; 95% confidence interval [CI]: 1.8\u201357.4%; p = 0.041; Fig. 2A) [36].",
            "startOffset": 29550,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 17601,
            "parents": [],
            "secId": "s0005",
            "sentence": "This invokes a T-cell response, resulting in antibodies and immune memory (non-highlighted portion of Fig. 1B).",
            "startOffset": 17490,
            "title": "Introduction"
        },
        {
            "endOffset": 30119,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 30118,
                    "startOffset": 30114
                }
            },
            "secId": "s0045",
            "sentence": "The current formulation of PHiD-CV showed a positive trend against NTHi AOM in an RCT (primary endpoint: likely bacterial community-acquired pneumonia) against control hepatitis A and B vaccines (intent-to-treat analysis 21.5%; 95% CI: \u221243.4% to 57.0%; not significant; Fig. 2B) [37].",
            "startOffset": 29835,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 28098,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 27977,
                    "startOffset": 27970
                },
                "b0145": {
                    "endOffset": 27977,
                    "startOffset": 27970
                }
            },
            "secId": "s0040",
            "sentence": "Although CRM carriers do not induce sufficient diphtheria-protective antibody levels in na\u00efve animals [28,29], based on the studies discussed in Section 2.1.3, they do appear to be immunogenic in humans immunized with infant DTaP.",
            "startOffset": 27868,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 19025,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0020",
            "sentence": "This is used in vaccines against tetanus and as a protein carrier in conjugated polysaccharide vaccines (Table 1).",
            "startOffset": 18911,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 40859,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0435": {
                    "endOffset": 40858,
                    "startOffset": 40854
                }
            },
            "secId": "s0090",
            "sentence": "PhtD and dPly have been tested as free proteins and protein carriers to an 8-valent PCV in a phase I trial in elderly people [87].",
            "startOffset": 40729,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 22354,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 22353,
                    "startOffset": 22349
                }
            },
            "secId": "s0025",
            "sentence": "A later study examined the immune response to DT carrier among girls aged 11\u201318 years who received various combinations of a human papillomavirus vaccine, tetanus-diphtheria-acellular pertussis (Tdap), and MenACWY_DT [17].",
            "startOffset": 22132,
            "title": "Diphtheria toxoid"
        },
        {
            "endOffset": 37357,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0075",
            "sentence": "This elicited higher levels of polymannuronic acid and flagellin antibodies in animal models; and significantly enhanced survival against lethal pneumonia due to 3/4 tested P. aeruginosa strains.",
            "startOffset": 37162,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 28280,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 28279,
                    "startOffset": 28275
                }
            },
            "secId": "s0040",
            "sentence": "This is supported by an animal study that showed very low anti-diphtheria antibody levels after one dose of CRM-conjugated vaccines, but much higher levels after a second dose [29].",
            "startOffset": 28099,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 43523,
            "parents": [],
            "secId": "s0110",
            "sentence": "However, the administration of multiple conjugate vaccinations containing the same carrier may increase the chance of immune interference.",
            "startOffset": 43385,
            "title": "Conclusions"
        },
        {
            "endOffset": 23810,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "All infants achieved protective diphtheria antibody levels (\u22650.1 IU/mL), as all received DTaP.",
            "startOffset": 23716,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 39262,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0410": {
                    "endOffset": 39141,
                    "startOffset": 39137
                }
            },
            "secId": "s0085",
            "sentence": "Maione et al. [82] tested the in vitro opsonophagocytic activity of mouse sera after immunization with GBS80, GBS67, GBS104, and/or GBS322.",
            "startOffset": 39123,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 43191,
            "parents": [],
            "secId": "s0110",
            "sentence": "The carrier proteins in glycoconjugate vaccines, included to improve immunogenicity to the polysaccharide, may also provide protection against the pathogen from which they are derived.",
            "startOffset": 43007,
            "title": "Conclusions"
        },
        {
            "endOffset": 41637,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0450": {
                    "endOffset": 41636,
                    "startOffset": 41632
                }
            },
            "secId": "s0095",
            "sentence": "E. coli glycoengineering technology has recently been used to create a vaccine containing S. aureus capsular polysaccharide conjugated to S. aureus \u03b1 toxin [90].",
            "startOffset": 41476,
            "title": "S. aureus"
        },
        {
            "endOffset": 42034,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0100",
            "sentence": "E. coli O157 strains that cause diarrhea-associated hemolytic uremic syndrome contain Shiga toxin 1 and/or 2.",
            "startOffset": 41925,
            "title": "E. coli"
        },
        {
            "endOffset": 45286,
            "parents": [],
            "secId": "s0130",
            "sentence": "Nimenrix is a trademark of the GSK group of companies, licensed to Pfizer.",
            "startOffset": 45212,
            "title": "Declaration"
        },
        {
            "endOffset": 23282,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "CRM is also used as a protein carrier in polysaccharide conjugate vaccines (Table 1).",
            "startOffset": 23197,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 32653,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 32652,
                    "startOffset": 32648
                },
                "b0240": {
                    "endOffset": 32568,
                    "startOffset": 32564
                }
            },
            "secId": "s0050",
            "sentence": "Genetically engineered meningococcal strains carrying nine Porin A genotypes have been constructed [48], but would likely cover < 75% of capsular group B strains circulating globally [47].",
            "startOffset": 32465,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 20570,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 20470,
                    "startOffset": 20466
                }
            },
            "secId": "s0020",
            "sentence": "A similar study among those aged \u226556 years in Lebanon showed a much smaller effect on anti-TT GMCs (2.4-fold vs. no increase) and fewer subjects with anti-tetanus antibodies \u22650.1 IU/mL (6\u201328% vs. no increase) [13], probably due to lower pre-vaccination anti-TT levels because of a paucity of prior TT vaccination.",
            "startOffset": 20257,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 27867,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0040",
            "sentence": "Therefore, TT and DT carriers may elicit protective \u201cadditional valency\u201d immunity even in na\u00efve recipients.",
            "startOffset": 27760,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 33727,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0060",
            "sentence": "Although studies have shown that TT-, DT-, or CRM-conjugated vaccines result in immune responses to TT or DT, such responses are only ever secondary/explorative analyses, so protection against tetanus or diphtheria is not included in the summaries of product characteristics.",
            "startOffset": 33452,
            "title": "Potential benefits"
        },
        {
            "endOffset": 25358,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "Those who received the CRM-conjugated vaccines 3\u20134 weeks before Tdap had significantly higher anti-diphtheria GMCs just prior to Tdap than those who received them 3\u20134 weeks after Tdap (1.78 vs. 0.27; p < 0.01); they also maintained slightly elevated levels 3\u20134 weeks after Tdap (2.39 vs. 1.78; p = 0.3).",
            "startOffset": 25055,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 35719,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0065",
            "sentence": "However, even if such immunological data were available, it would be difficult to quantify the differences in immune responses and their potential clinical relevance.",
            "startOffset": 35553,
            "title": "Potential limitations"
        },
        {
            "endOffset": 39944,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0415": {
                    "endOffset": 39943,
                    "startOffset": 39939
                }
            },
            "secId": "s0085",
            "sentence": "The best results were found with tyrosine-directed ligation and thiol-maleimide addition [83].",
            "startOffset": 39850,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 41915,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0450": {
                    "endOffset": 41914,
                    "startOffset": 41910
                }
            },
            "secId": "s0095",
            "sentence": "By using S. aureus protein antigens as dual function protein carriers, more antigens can be delivered in a multivalent vaccine, thus minimizing the number of vaccine components [90].",
            "startOffset": 41733,
            "title": "S. aureus"
        },
        {
            "endOffset": 34283,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0060",
            "sentence": "For example, it may be possible to reduce the recommended number of Td boosters or, in countries with low compliance to regular Td boosters, improve the tetanus and diphtheria antibody persistence in the population thanks to a dual effect of TT-, DT-, and CRM-containing conjugates.",
            "startOffset": 34001,
            "title": "Potential benefits"
        },
        {
            "endOffset": 38308,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0080",
            "sentence": "Such vaccines could potentially prevent bacterial colonization and neutralize toxin activity.",
            "startOffset": 38215,
            "title": "Costridium difficile"
        },
        {
            "endOffset": 32972,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0050",
            "sentence": "There is currently only one licensed vaccine that uses OMPC as a carrier protein \u2013 Hib_OMPC (Table 1).",
            "startOffset": 32870,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 36759,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0075",
            "sentence": "These new-generation \u201cbioconjugate\u201d vaccines are based on in vivo-produced glycoconjugates and are currently being evaluated.",
            "startOffset": 36634,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 18236,
            "parents": [],
            "secId": "s0005",
            "sentence": "This phenomenon has largely been overlooked.",
            "startOffset": 18192,
            "title": "Introduction"
        },
        {
            "endOffset": 41475,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0445": {
                    "endOffset": 41474,
                    "startOffset": 41470
                }
            },
            "secId": "s0095",
            "sentence": "Vaccines against S. aureus will probably require multiple antigens including capsular polysaccharides [89].",
            "startOffset": 41368,
            "title": "S. aureus"
        },
        {
            "endOffset": 22490,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 22489,
                    "startOffset": 22485
                }
            },
            "secId": "s0025",
            "sentence": "The DT GMC 1 month after vaccination was approximately 3.7-fold higher among girls who received all three vaccines vs. Tdap alone [17].",
            "startOffset": 22355,
            "title": "Diphtheria toxoid"
        },
        {
            "endOffset": 33361,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0050",
            "sentence": "Due to the wide sequence variation, such antibodies are unlikely to have a significant \u201cadditional valency\u201d benefits from a public health perspective.",
            "startOffset": 33211,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 44546,
            "parents": [],
            "secId": "s0120",
            "sentence": "MB is an inventor of a patent application dealing with conjugate vaccines.",
            "startOffset": 44472,
            "title": "Disclosures"
        },
        {
            "endOffset": 36969,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0365": {
                    "endOffset": 36968,
                    "startOffset": 36964
                }
            },
            "secId": "s0075",
            "sentence": "Trials using EPA-based glycoconjugates have demonstrated a correlation of anti-EPA IgG titers with EPA-neutralizing titers, confirming that the B-cell epitopes for neutralizing antibodies were maintained [73].",
            "startOffset": 36760,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 44958,
            "parents": [],
            "secId": "s0125",
            "sentence": "GlaxoSmithKline Biologicals S.A. funded all costs related to the development of this publication.",
            "startOffset": 44861,
            "title": "Sources of support"
        },
        {
            "endOffset": 39042,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0405": {
                    "endOffset": 39041,
                    "startOffset": 39037
                }
            },
            "secId": "s0085",
            "sentence": "A vaccine in which GBS type II polysaccharide was conjugated to GBS80 pilus protein elicited antibodies in mice and protected the newborn mice of vaccinated mothers [81].",
            "startOffset": 38872,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 17489,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 17488,
                    "startOffset": 17485
                }
            },
            "secId": "s0005",
            "sentence": "The lack of a T-cell response with polysaccharide vaccines has been overcome by conjugation to protein carriers [4].",
            "startOffset": 17373,
            "title": "Introduction"
        },
        {
            "endOffset": 24169,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "In this study, a diphtheria antibody level \u22651.0 IU/mL was considered protective; induced in 95% vs. 82% of participants.",
            "startOffset": 24049,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 39122,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "Further, that the GBS80 pilus protein carrier was similarly efficacious as CRM.",
            "startOffset": 39043,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 41732,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0095",
            "sentence": "This vaccine provided broad-spectrum efficacy against staphylococcal invasive disease in mice.",
            "startOffset": 41638,
            "title": "S. aureus"
        },
        {
            "endOffset": 37955,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0390": {
                    "endOffset": 37954,
                    "startOffset": 37950
                }
            },
            "secId": "s0080",
            "sentence": "Romano et al. conjugated the most abundantly expressed of the three C. difficile cell-surface polysaccharides (PSII) to recombinant CDTA and C. difficile toxin B (CDTB) fragments to form homovalent vaccines [78].",
            "startOffset": 37743,
            "title": "Costridium difficile"
        },
        {
            "endOffset": 44630,
            "parents": [],
            "secId": "s0120",
            "sentence": "IV holds shares in the GSK group of companies as part of his employee remuneration.",
            "startOffset": 44547,
            "title": "Disclosures"
        },
        {
            "endOffset": 18910,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0020",
            "sentence": "Tetanus toxin, which causes the clinical manifestations of tetanus, can be chemically inactivated to TT.",
            "startOffset": 18806,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 34900,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "refoffsets": {
                "b0285": {
                    "endOffset": 34899,
                    "startOffset": 34895
                }
            },
            "secId": "s0065",
            "sentence": "A recent meta-analysis of RCTs in which infants received Hib_TT plus meningococcal or pneumococcal conjugate vaccines found that PHiD-CV, MenACWY_CRM, PCV7_CRM, and MenC_CRM resulted in a 41% increase, a 22% increase, no significant impact, and a 45% reduction, respectively, in Hib antibody concentrations [57].",
            "startOffset": 34588,
            "title": "Potential limitations"
        },
        {
            "endOffset": 41210,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0440": {
                    "endOffset": 41209,
                    "startOffset": 41205
                }
            },
            "secId": "s0090",
            "sentence": "A recent preclinical study that tested various pneumococcal and other bacterial proteins as potential carriers found that Laminarin_spr96/2021 induced a significantly higher immune response to Laminarin and similar anti-carrier IgG levels vs. Laminarin_CRM [88].",
            "startOffset": 40948,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 32773,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0245": {
                    "endOffset": 32772,
                    "startOffset": 32768
                }
            },
            "secId": "s0050",
            "sentence": "An investigational MenB-Hib_OMPC vaccine has been found to elicit a capsular group Y meningococcal (MenY) response [49].",
            "startOffset": 32653,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 29229,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 29228,
                    "startOffset": 29224
                }
            },
            "secId": "s0045",
            "sentence": "Hyperimmunization of rats with a non-acylated form of protein D induced immunoglobulin A (IgA) and IgG antibodies with significant bactericidal activity against various H. influenzae strains [32].",
            "startOffset": 29033,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 44471,
            "parents": [],
            "secId": "s0120",
            "sentence": "MB, FB, and IV are employees of the GSK group of companies, a pharmaceutical company that produces and distributes conjugate vaccines.",
            "startOffset": 44337,
            "title": "Disclosures"
        },
        {
            "endOffset": 21317,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 21316,
                    "startOffset": 21312
                }
            },
            "secId": "s0020",
            "sentence": "Various RCTs of capsular group A meningococcal conjugate vaccine (MenA_TT) in Africa have shown that it elicits robust tetanus-specific immune responses among those aged 1\u201329 years, similar to those after a TT booster [15].",
            "startOffset": 21094,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 34000,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0060",
            "sentence": "If clinical studies could be carried out, with suitable primary endpoints (and lethal challenge animal data are accepted for predicting protection in humans), it may be possible to reconsider vaccination schedules, accounting for the protective effect of carrier proteins.",
            "startOffset": 33728,
            "title": "Potential benefits"
        },
        {
            "endOffset": 35442,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "refoffsets": {
                "b0295": {
                    "endOffset": 35441,
                    "startOffset": 35437
                }
            },
            "secId": "s0065",
            "sentence": "However, 1 month after the fourth dose (at 15 months), most antibody levels (apart from pertussis toxin) were not significantly different in the two groups [59].",
            "startOffset": 35281,
            "title": "Potential limitations"
        },
        {
            "endOffset": 19464,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 19463,
                    "startOffset": 19460
                }
            },
            "secId": "s0020",
            "sentence": "A study in adult volunteers showed an increase in TT antibodies after one dose of Hib_TT (21\u2013185 U/mL) or pneumococcus type 6A_TT (15\u2013134 U/mL), but little further increase after a second dose 3 weeks later [9].",
            "startOffset": 19253,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 20141,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 20082,
                    "startOffset": 20078
                },
                "b0055": {
                    "endOffset": 20140,
                    "startOffset": 20133
                },
                "b0060": {
                    "endOffset": 20140,
                    "startOffset": 20133
                }
            },
            "secId": "s0020",
            "sentence": "This was significant in one study [10], but significance was not mentioned in the others [11,12].",
            "startOffset": 20044,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 17204,
            "parents": [],
            "secId": "s0005",
            "sentence": "Polysaccharide vaccines only elicit a B-cell response, so although antibodies are produced, there is no long-term memory (Fig. 1A).",
            "startOffset": 17073,
            "title": "Introduction"
        },
        {
            "endOffset": 30519,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0195": {
                    "endOffset": 30518,
                    "startOffset": 30514
                }
            },
            "secId": "s0045",
            "sentence": "Further, PHiD-CV introduction in Kenya was followed by a reduction in NTHi carriage in the first 2 years [39].",
            "startOffset": 30409,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 43384,
            "parents": [],
            "secId": "s0110",
            "sentence": "Vaccines containing TT, DT, or CRM carriers may provide sufficient boosting against tetanus/diphtheria, thus removing or reducing the need for additional tetanus-/diphtheria-specific boosters.",
            "startOffset": 43192,
            "title": "Conclusions"
        },
        {
            "endOffset": 20256,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 20255,
                    "startOffset": 20251
                },
                "b0055": {
                    "endOffset": 20184,
                    "startOffset": 20177
                },
                "b0060": {
                    "endOffset": 20184,
                    "startOffset": 20177
                }
            },
            "secId": "s0020",
            "sentence": "Of note, the cut-off of \u22650.1 IU/mL [10\u201312] was higher than considered minimally seroprotective (\u22650.01 IU/mL) [10].",
            "startOffset": 20142,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 40947,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0090",
            "sentence": "Anti-Ply and -PhtD antibody responses were found for free and conjugated PhtD and dPly.",
            "startOffset": 40860,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 29383,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 29350,
                    "startOffset": 29346
                },
                "b0170": {
                    "endOffset": 29382,
                    "startOffset": 29378
                }
            },
            "secId": "s0045",
            "sentence": "Activity of protein D against NTHi infection has been demonstrated in rat middle ear and pulmonary clearance models [33] and a chinchilla AOM model [34].",
            "startOffset": 29230,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 41356,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0440": {
                    "endOffset": 41355,
                    "startOffset": 41351
                }
            },
            "secId": "s0090",
            "sentence": "Various meningococcal serogroup polysaccharides conjugated to spr96/2021 resulted in comparable immune responses to those conjugated to CRM [88].",
            "startOffset": 41211,
            "title": "S. pneumoniae"
        },
        {
            "endOffset": 22131,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 22130,
                    "startOffset": 22126
                }
            },
            "secId": "s0025",
            "sentence": "A study in adult volunteers showed that Streptococcus pneumoniae type 12F polysaccharide conjugated to DT resulted in a significant 12\u201317-fold increase in DT antibody levels (p < 0.001) [16].",
            "startOffset": 21940,
            "title": "Diphtheria toxoid"
        },
        {
            "endOffset": 35280,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "refoffsets": {
                "b0290": {
                    "endOffset": 35279,
                    "startOffset": 35275
                }
            },
            "secId": "s0065",
            "sentence": "In a controlled cohort study, Tdap vs. no vaccination during pregnancy resulted in significantly higher TT, DT, and pertussis toxin antibody levels among infants before their primary series, but significantly lower levels of DT and pertussis toxin 4 weeks after the primary series [58].",
            "startOffset": 34994,
            "title": "Potential limitations"
        },
        {
            "endOffset": 36633,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0365": {
                    "endOffset": 36606,
                    "startOffset": 36599
                },
                "b0370": {
                    "endOffset": 36606,
                    "startOffset": 36599
                },
                "b0375": {
                    "endOffset": 36623,
                    "startOffset": 36619
                }
            },
            "secId": "s0075",
            "sentence": "Detoxified recombinant EPA has been used as a carrier for heterovalent Shigella dysenteriae [73,74] and E. coli [75] vaccines.",
            "startOffset": 36507,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 38214,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0080",
            "sentence": "Both glycoconjugates induced anti-protein carrier IgG (particularly PSII_CDTB) and retained their toxin-neutralizing activity.",
            "startOffset": 38088,
            "title": "Costridium difficile"
        },
        {
            "endOffset": 26358,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 26357,
                    "startOffset": 26353
                }
            },
            "secId": "s0040",
            "sentence": "In the primary stage of one study, 6\u201312-week-old babies were randomized to Hib-MenC_TT plus DTaP-IPV or MenC_CRM plus DTaP-IPV-Hib_TT [26].",
            "startOffset": 26219,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 43725,
            "parents": [],
            "secId": "s0110",
            "sentence": "Future polysaccharide conjugate vaccine efficacy trials should be designed to additionally study antibody response to the carrier as a primary outcome.",
            "startOffset": 43574,
            "title": "Conclusions"
        },
        {
            "endOffset": 37161,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0380": {
                    "endOffset": 37160,
                    "startOffset": 37156
                }
            },
            "secId": "s0075",
            "sentence": "In an attempt to design a broadly protective P. aeruginosa vaccine, two P. aeruginosa components \u2013 polymannuronic acid and type a flagellin \u2013 have been combined in a homovalent conjugate [76].",
            "startOffset": 36969,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 34466,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "refoffsets": {
                "b0260": {
                    "endOffset": 34465,
                    "startOffset": 34458
                },
                "b0265": {
                    "endOffset": 34465,
                    "startOffset": 34458
                },
                "b0270": {
                    "endOffset": 34465,
                    "startOffset": 34458
                }
            },
            "secId": "s0065",
            "sentence": "Administration of multiple conjugate vaccinations with the same carrier may increase the chance of immune interference, as reviewed by various authors [52\u201354].",
            "startOffset": 34307,
            "title": "Potential limitations"
        },
        {
            "endOffset": 37743,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0080",
            "sentence": "The resultant heterovalent conjugates elicited high levels of IgG to the polysaccharides and CDTA in mice; and the anti-CDTA had in vitro toxin-neutralizing and protective activity.",
            "startOffset": 37562,
            "title": "Costridium difficile"
        },
        {
            "endOffset": 31500,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0225": {
                    "endOffset": 31499,
                    "startOffset": 31495
                }
            },
            "secId": "s0045",
            "sentence": "Compared with children who received PHiD-CV, those who received PCV13_CRM had significantly higher levels of NTHi-infected ear discharge (Fig. 3B) [45].",
            "startOffset": 31348,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 24650,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0030",
            "sentence": "Prior to the booster, 94% vs. 51% had protective diphtheria antibody levels (\u22650.1 IU/mL), rising to 100% vs. 99% after the booster.",
            "startOffset": 24519,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 32869,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0050",
            "sentence": "This is likely because the composition of the MenB OMPC is similar to many of the MenY strains.",
            "startOffset": 32774,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 31713,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "secId": "s0045",
            "sentence": "Overall, further studies on the effect of PHiD-CV on the prevention of NTHi AOM are warranted.",
            "startOffset": 31619,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 22693,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "secId": "s0025",
            "sentence": "All girls achieved protective diphtheria antibody levels (\u22650.1 IU/mL), as would be expected after Tdap, but these results show that DT-conjugated vaccines appear to have a cumulative immunogenic effect.",
            "startOffset": 22491,
            "title": "Diphtheria toxoid"
        },
        {
            "endOffset": 38735,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0400": {
                    "endOffset": 38734,
                    "startOffset": 38730
                }
            },
            "secId": "s0085",
            "sentence": "GBS pilus protein can be used as a carrier protein for GBS capsular polysaccharides, and could result in broader strain coverage [80].",
            "startOffset": 38601,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 32206,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0235": {
                    "endOffset": 32166,
                    "startOffset": 32162
                },
                "b0240": {
                    "endOffset": 32205,
                    "startOffset": 32201
                }
            },
            "secId": "s0050",
            "sentence": "Outer membrane protein complexes (OMPCs) of N. meningitidis capsular group B can be used to vaccinate against meningococcal disease, but due to wide variations in sequences across isolates, such vaccinations are only useful in epidemics dominated by one strain [47] or if multiple OMPCs are combined [48].",
            "startOffset": 31901,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 38087,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0080",
            "sentence": "In a na\u00efve mouse model, PSII_CDTB elicited anti-PSII IgG titers comparable to PSII_CRM, with PSII_CDTA eliciting lower mean levels.",
            "startOffset": 37956,
            "title": "Costridium difficile"
        },
        {
            "endOffset": 42235,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0455": {
                    "endOffset": 42234,
                    "startOffset": 42230
                }
            },
            "secId": "s0100",
            "sentence": "Vaccines containing detoxified E. coli O157 lipopolysaccharide conjugated to Shiga toxin 1 elicited bactericidal antibodies to E. coli O157 and neutralization antibodies to Shiga toxin 1 in mice [91].",
            "startOffset": 42035,
            "title": "E. coli"
        },
        {
            "endOffset": 27161,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 27160,
                    "startOffset": 27156
                }
            },
            "secId": "s0040",
            "sentence": "Tetanus responses were 1.5\u20131.7-fold higher among MenC_TT recipients (significant), while diphtheria responses were 1.1\u20131.2-fold higher among MenC_CRM recipients (not significant) [27].",
            "startOffset": 26977,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 33210,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0255": {
                    "endOffset": 33209,
                    "startOffset": 33205
                }
            },
            "secId": "s0050",
            "sentence": "However, although antibodies to the OMPC of N. meningitidis are produced, their clinical relevance is unclear [51].",
            "startOffset": 33095,
            "title": "Outer membrane protein complexes of Neisseria meningitidis capsular group B"
        },
        {
            "endOffset": 24048,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 24047,
                    "startOffset": 24043
                }
            },
            "secId": "s0030",
            "sentence": "Those who received MenACWY_CRM vs. placebo had a larger increase in anti-diphtheria GMCs (39- vs. 15-fold) [22].",
            "startOffset": 23936,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 38401,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "Group B Streptococcus (GBS) can cause serious infections in neonates.",
            "startOffset": 38332,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 35850,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0065",
            "sentence": "This possible problem could, however, be at least partially solved by the use of different protein carriers in different vaccines.",
            "startOffset": 35720,
            "title": "Potential limitations"
        },
        {
            "endOffset": 25649,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 25648,
                    "startOffset": 25644
                }
            },
            "secId": "s0030",
            "sentence": "The authors concluded that \u201cthe carrier protein CRM197 per se can induce substantial immune response against diphtheria\u201d [24].",
            "startOffset": 25523,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 27360,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 27247,
                    "startOffset": 27240
                },
                "b0135": {
                    "endOffset": 27247,
                    "startOffset": 27240
                }
            },
            "secId": "s0040",
            "sentence": "Although > 99% of subjects had TT and DT antibodies \u22650.1 IU/mL, these studies [26,27] imply that a CRM carrier can enhance the immune response against diphtheria in infants concomitantly given DTaP.",
            "startOffset": 27162,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 18041,
            "parents": [],
            "secId": "s0005",
            "sentence": "The carrier protein also induces an immune response to itself (highlighted portion of Fig. 1B).",
            "startOffset": 17946,
            "title": "Introduction"
        },
        {
            "endOffset": 36506,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0075",
            "sentence": "However, despite EPA neutralizing and anti-polysaccharide antibody responses and some polysaccharide-mediated clinical efficacy, there are no licensed vaccines based on EPA conjugates.",
            "startOffset": 36322,
            "title": "Pseudomonas aeruginosa"
        },
        {
            "endOffset": 19252,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 19251,
                    "startOffset": 19248
                }
            },
            "secId": "s0020",
            "sentence": "Administration of conjugated Hib_TT resulted in an increase in TT antibodies in monkeys with high preexisting TT antibodies (from 17 to 121\u2013193 units/mL), but not in those with lower TT antibodies (0.1 units/mL throughout) [8].",
            "startOffset": 19025,
            "title": "Tetanus toxoid"
        },
        {
            "endOffset": 23197,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 23196,
                    "startOffset": 23192
                }
            },
            "secId": "s0030",
            "sentence": "CRM in a non-conjugated TT-CRM combination vaccine (where DT was replaced by CRM) elicited a similar increase in diphtheria antibodies to tetanus-diphtheria (Td) vaccine in primed adults [20].",
            "startOffset": 23005,
            "title": "Cross-reacting material 197"
        },
        {
            "endOffset": 42703,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0100",
            "sentence": "The authors postulated that such a vaccine could be protective against a wide range of Shiga toxin-producing E. coli serogroups.",
            "startOffset": 42575,
            "title": "E. coli"
        },
        {
            "endOffset": 38872,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "secId": "s0085",
            "sentence": "In this case, the carrier protein valency would clearly be part of the intended vaccine formulation rather than an \u201cadditional valency\u201d.",
            "startOffset": 38736,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 39651,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0415": {
                    "endOffset": 39450,
                    "startOffset": 39446
                }
            },
            "secId": "s0085",
            "sentence": "Nilo et al. [83] synthesized GBS glycoconjugates using copper-free strain-promoted azide-alkyne [3 + 2] cycloaddition or thiol-maleimide addition to connect GBS type V to predetermined residues of GBS67 pilus protein.",
            "startOffset": 39434,
            "title": "Group B Streptococcus"
        },
        {
            "endOffset": 28430,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                },
                {
                    "id": "s0015",
                    "title": "Toxoids"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 28429,
                    "startOffset": 28425
                }
            },
            "secId": "s0040",
            "sentence": "Also, anti-diphtheria antibody levels after two doses of CRM-conjugated vaccines were similar to those after one dose of DT-conjugated vaccines [29].",
            "startOffset": 28281,
            "title": "Studies comparing TT, DT, and CRM carriers"
        },
        {
            "endOffset": 34993,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Potential implications of the \u201chidden valency\u201d carrier protein effect"
                }
            ],
            "secId": "s0065",
            "sentence": "Also, maternal immunization with conjugate vaccines may affect infant immunization responses.",
            "startOffset": 34900,
            "title": "Potential limitations"
        },
        {
            "endOffset": 31091,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0220": {
                    "endOffset": 31066,
                    "startOffset": 31062
                },
                "b0225": {
                    "endOffset": 31090,
                    "startOffset": 31086
                }
            },
            "secId": "s0045",
            "sentence": "The impact of PHiD-CV on NTHi AOM after its introduction in national immunization programs has been shown in two Australian studies in Aboriginal children \u2013 who are at increased risk of AOM \u2013 where PCV7_CRM/23-valent pneumococcal polysaccharide vaccine (PPV23) was replaced by PHiD-CV [44] and then PCV13_CRM [45].",
            "startOffset": 30777,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 17072,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17071,
                    "startOffset": 17066
                },
                "b0010": {
                    "endOffset": 17071,
                    "startOffset": 17066
                }
            },
            "secId": "s0005",
            "sentence": "The development of vaccines against polysaccharide-encapsulated pathogens is challenging due to an insufficient immune response to the polysaccharides, particularly in young children [1,2].",
            "startOffset": 16883,
            "title": "Introduction"
        },
        {
            "endOffset": 30408,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Antibody responses to currently used carrier proteins"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 30407,
                    "startOffset": 30403
                },
                "b0190": {
                    "endOffset": 30234,
                    "startOffset": 30230
                }
            },
            "secId": "s0045",
            "sentence": "Although no significant reduction of nasopharyngeal NTHi carriage was observed in a subpopulation of this RCT [38], the 11-valent predecessor to PHiD-CV showed a trend towards a reduction in NTHi nasopharyngeal carriage at age 15\u201318 months (41.4%; 95% CI: \u22124.9% to 67.3%; p = 0.075) [36].",
            "startOffset": 30120,
            "title": "Protein D of non-typeable H. influenzae"
        },
        {
            "endOffset": 42448,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Potential new carrier protein sources"
                }
            ],
            "refoffsets": {
                "b0460": {
                    "endOffset": 42447,
                    "startOffset": 42443
                }
            },
            "secId": "s0100",
            "sentence": "More recently, \u03b2-(1\u20136)-linked poly-N-acetylglucosamine (PNAG) surface polysaccharide (produced by various pathogens including E. coli) was conjugated to the Shiga toxin 1b subunit and tested in animal models [92].",
            "startOffset": 42235,
            "title": "E. coli"
        }
    ],
    "docId": "S0264410X17305790",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "michael.broeker@yahoo.de",
                "first": "Michael",
                "initial": "M.",
                "last": "Br\u00f6ker"
            },
            {
                "email": "francesco.x.berti@gsk.com",
                "first": "Francesco",
                "initial": "F.",
                "last": "Berti"
            },
            {
                "email": "joerg.x.schneider@gsk.com",
                "first": "Joerg",
                "initial": "J.",
                "last": "Schneider"
            },
            {
                "email": "ivo.x.vojtek@gsk.com",
                "first": "Ivo",
                "initial": "I.",
                "last": "Vojtek"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.04.078",
        "firstpage": "3286",
        "issn": "0264410X",
        "keywords": [
            "Diphtheria toxoid",
            "Neglected valency",
            "Polysaccharide conjugate vaccines",
            "Protein D of non-typeable Haemophilus influenzae",
            "Protein carriers",
            "Tetanus toxoid"
        ],
        "lastpage": "3294",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Polysaccharide conjugate vaccine protein carriers as a \u201cneglected valency\u201d \u2013 Potential and limitations"
    }
}